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ABSTRACT 
 
Traditional medicines form a significant part of the lives of many people around the world 
and in South Africa almost 60 % of people consult traditional healers in addition to the 
modern medical services available. Plants form a significant part of traditional healing and 
hence, selected species of a traditionally used plant genus, Hermannia, were chosen for 
biological and chemical investigation to determine a scientific basis for the traditional use 
of these plants. 
 
A phytochemical investigation was carried out, firstly using thin layer chromatography 
(TLC) and high performance liquid chromatography (HPLC) and then isolation and 
identification of compounds from various Hermannia species. TLC analysis indicated 
significant similarities between the various species with only H. saccifera displaying 
chemical anomalies. This was further corroborated by the HPLC analysis although very 
conservative profiles were produced. Isolation of compounds from H. saccifera yielded a 
novel labdane compound, E-17, 19-diacetoxy - 15 - hydroxylabda - 7,13 - diene, as well as 
two flavones, 5,8- dihydroxy-6,7,4’- trimethoxyflavone and cirsimaritin which have 
previously been isolated. In addition, two commonly found compounds, lupeol and β-
sitosterol were isolated from H. cuneifolia and H. salviifolia respectively. This is the first 
report on the isolation and identification of all five compounds from Hermannia species. 
 
Antimicrobial activity was assessed using two methods i.e. minimum inhibitory 
concentrations as well as the death kinetics assay. Minimum inhibitory concentrations were 
determined using four Gram-positive and two Gram-negative bacteria as well as two 
yeasts. All species investigated indicated antimicrobial activity with H. saccifera showing 
good activity against S. aureus and B. cereus. E-17, 19-diacetoxy - 15 - hydroxylabda - 
7,13 - diene isolated from H. saccifera indicated activity (MIC = 23.6 µg/ml against S. 
 VII 
aureus) although the activity was less than that of the crude extract (MIC = 19.5 µg/ml), 
thus, demonstrating that there are a number of compound contributing to the promising 
activity of the crude extract. This was further corroborated by the bioautograms developed 
of the H. saccifera extract. Time-kill studies on H. saccifera against S. aureus indicated 
that  at concentrations of 0.1, 0.25 and 0.5 % bacteriostatic activity was observed while at 
0.75% the extract achieved complete bactericidal activity after 240min.   
 
Free radical scavenging activity was assessed using the 2,2-diphenyl-1-picrylhydrazy 
(DPPH) and 2,2′-azino-bis(3-ethyl-benzthiazoline-6-sulfonic acid) (ABTS) assays. Ten of 
the twelve species indicated good activity with H. cuneifolia demonstrating the most 
promising activity (IC50 = 10.26 µg/ml for DPPH and 10.32 µg/ml for ABTS). Two of the 
isolated compound, 5,8- dihydroxy-6,7,4’- trimethoxyflavone and cirsimaritin displayed 
insignificant activity. 
 
The 5-lipoxygenase assay was used to assess the anti-inflammatory activity of Hermannia 
species. All species exhibited intermediate activity with the exception of H. cuneifolia 
(IC50 = 15.32 µg/ml). In addition, four isolated compounds, 5,8- dihydroxy-6,7,4’- 
trimethoxyflavone, cirsimaritin, lupeol and β-sitosterol showed moderate inhibition of the 
enzyme indicating that while these compounds do contribute to the activity of the extracts 
they are not individually responsible for any significant activity. 
 
Antimalarial activity was assessed using the titrated hypoxanthine incorporation assay 
while toxicity was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide (MTT) cell proliferation assay. Only three species indicated any good 
antimalarial activity i.e. H. saccifera, H. muricata and mostly H. trifurca (IC50 = 25.30, 
28.17 and 18.80 µg/ml respectively). However, the activity of H. saccifera and H. trifurca 
 VIII 
are probably due to a general cytotoxicity as these species exhibited a low safety index. All 
other species appear safe for use. 
 
Several Hermannia species have indicated in vitro biological activity in a number of assays 
which is related to their use in traditional medicines to treat a number of disease states. 
Hence, a scientific basis, albeit in vitro, has been established for the use Hermannia 
species in traditional healing.  
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1 
CHAPTER 1: GENERAL INTRODUCTION 
 
1.1. PLANTS AND THEIR USE AS TRADITIONAL MEDICINES: 
Plants are essential for all life on earth since they convert solar energy into organic 
compounds and have the remarkable capacity of producing carbohydrates, proteins, fats 
and vitamins and, most importantly, oxygen. In addition, the “phytochemical laboratory” 
produces countless secondary metabolites. These compounds often are the most 
conspicuous of the constituents of a plant and have been in use for many purposes since 
prehistoric times. Constituents with special properties often occur in a high concentration 
and sometimes with great purity in a particular plant (Neuwinger, 1994).  
 
A number of theories have been proposed as to why these compounds are produced but it 
is highly likely that many of them are produced as part of a chemical defense system to 
protect the plant from attack. Examples of this defense include the synthesis of 
antimicrobial compounds by plants, which may be infected by bacteria and fungi. 
Whatever the reasons for the presence of these compounds in Nature, they are an 
invaluable resource that can be used to find new molecules for the pharmaceutical domain. 
 
 A perceived benefit of compounds derived from nature is that they are ‘ecofriendly’ and 
that they may be produced as a renewable resource by growing the plants. This approach 
has both advantages and disadvantages over the synthetic production of biologically active 
agents. But synthetic chemistry cannot readily mimic the ability of organisms to produce 
such structurally complex and diverse natural product molecules. This incredible genetic 
resource could potentially generate millions of natural products to be assessed for 
biological activity.  
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While plants have adapted to the diverse habitats of the world through their physical and 
biochemical modifications, human populations have adapted largely through generation 
and application of knowledge. Today, traditional societies throughout the world posses a 
wealth of such knowledge which they have accumulated during prolonged interaction with 
the natural world, and which remains fundamental to their physical, spiritual and social 
well-being (Cotton, 1996). 
 
The history of pharmacy was for centuries identical with the history of Pharmacognosy, or 
the study of materia medica, which were obtained from natural sources, mostly plants (van 
Wyk and Wink, 2004). Written records about medicinal plants date back at least 500 years 
and may possibly extend to as early as the Sumerians. In addition, archaeological evidence 
suggests an even earlier use than this. However, the strong bond between plants and human 
health began to unwind in 1897, when Friedrich Bayer and Co. introduced synthetic acetyl 
salicylic acid (aspirin) to the world. Thus the twentieth century became a triumph for the 
synthetic-chemistry-dominated pharmaceutical industry, which replaced natural extracts 
with synthetic molecules.  
 
However, this benefit of modern drugs is felt primarily in developed countries (Raskin et 
al., 2002). An estimated one-third of the world lacks regular access to essential drugs, with 
this figure rising to 50% in the poorer parts of Africa and Asia (WHO, 2000) and thus, 
these people are reliant on their own knowledge of traditional medicines to cater for their 
health care requirements. 
 
It is likely that the profound knowledge of herbal remedies in traditional cultures 
developed through trial and error over many centuries, and that the most important cures 
were carefully passed on verbally from one generation to the next. It is hard to dismiss 
medical claims of safety and efficacy when a plant medicine has been used by these 
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traditional cultures for centuries without evidence of serious side effects (Heinrich et al., 
2004). It is only within the last few decades that research results generated have given us a 
much better understanding of the scientific rationale behind many natural remedies. 
Phytomedicines often contain a mixture of substances that have additive or even 
synergistic effects, so that the health benefits are difficult to test and verify. Plant medicine 
or phytomedicines may have subtle effects on several different biochemical pathways and 
receptors in the body-mind continuum that may all contribute directly and indirectly to 
restore equilibrium and balance (van Wyk and Wink, 2004). 
  
African traditional medicine, itself, is the oldest and perhaps most diverse of all medicine 
systems. The biological and cultural diversity of Africa that constitutes the cradle of 
mankind is reflected in the marked regional differences in healing practices. Unfortunately, 
the various systems are poorly recorded and remain so to this day (van Wyk and Wink, 
2004).  
 
African traditional medicine in its varied forms is a holistic system involving both body 
and mind. The healer typically diagnoses and treats the psychological basic of an illness 
before prescribing medicines to treat the symptoms. The Khoi-San people of Southern 
Africa, nowadays considered to be the most ancient of all cultures, have an extraordinarily 
diverse materia medica which typically includes general tonics, fever remedies, sedatives, 
diuretics, laxatives and numerous wound healing plants (van Wyk and Wink, 2004). This is 
not exceptional, however, when considering that of the estimated 300 000 species of plants 
which exist throughout the world (Cotton, 1996), Southern Africa has the richest temperate 
flora and encompasses a rich floristic diversity. There are approximately 24 000 taxa of 
368 families, including more than 10% of the world’s vascular plant flora on less than 
2.5% of the Earth’s land surface (Germisthuizen and Meyer, 2003).  
  
4 
 
1.1.2. Extent of traditional use and its importance in the South African context 
It is thought that 80% of the population of the world live in less developed countries and 
the World Health Organization estimates that about 80% of these people rely exclusively 
on traditional medicine, for which medicinal plants form the ‘backbone’ to satisfy their 
primary health-care needs (WHO, 2003). 
 
There are an estimated 200 000 traditional healers in South Africa, and up to 60% of South 
Africans consult these healers, usually in addition to modern biomedical services. With 
South Africa’s immense floristic and cultural diversity, it is not surprising to find that 
approximately 3 000 species of plants are used as medicines, and of these, some 350 
species are the most commonly used and traded medicinal plants (van Wyk and Wink, 
2004). 
 
The problem is that the usefulness of these traditional remedies has not been systematically 
investigated, and the country is therefore not in a position to benefit from this significant 
genetic resource and indigenous knowledge base. Such an evaluation is urgent, since 
urbanization and other factors are rapidly reducing the availability of first-hand 
information on traditional medicines (Long and Li, 2003). Since medicinal plants and 
plant-derived medicine are so widely used in traditional cultures all over the world and are 
becoming increasingly popular in modern society as natural alternatives to synthetic 
chemicals (van Wyk and Wink, 2004), it is a necessity to obtain information on 
compounds contained within the extracts that possess biological activity, their contribution 
to the entire effect of the extracts which may include synergistic or antagonistic effects, as 
well as potential toxicity of the extracts as well as the constituents. 
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1.1.3. Pharmacognosy, ethnobotany and the necessity for research into traditional 
medicines. 
Pharmacognosy is the study of medical products derived from our living environment, 
especially those derived from plants and fungi while ethnobotany studies the relationship 
between humans and plants in all its complexity. Many drugs that are commonly used 
today came into use through the study of indigenous remedies – that is, through the 
bioscientific investigation of plants used by people throughout the world. Ethnobotany and 
Pharmacognosy are interdisciplinary fields of research that look specifically at the 
empirical knowledge of indigenous peoples concerning medicinal substances, their 
potential health benefits and the potential toxicity risks associated with such remedies 
(Heinrich et al., 2004).  
 
The popularity of traditional medicines has led to increasing concerns over their safety, 
quality and efficacy. In many countries the herbal medicines market is poorly regulated 
and products may be neither registered nor controlled. National surveillance systems used 
to monitor and evaluate adverse effects are rare (Camejo-Rodrigues et al., 2003).  This is 
surprising when you consider that during the latter part of the 20th century herbalism has 
become mainstream worldwide partly due to the perception that herbal remedies are 
somehow safer and more efficacious than remedies that are pharmaceutically derived 
(Elvin-Lewis, 2001). 
 
 In addition, chemo diversity in Nature, such as in plants, still offers a valuable source for 
novel lead discovery (Tringali, 2001). There are a number of approaches that can be used 
to discover new drug leads from nature. In the ethnobotanical approach, knowledge of the 
use of a particular plant by indigenous people is used to direct a search for a drug lead. In 
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this case, observation of a particular usage of a plant, allows the collection of that plant and 
its subsequent testing for biological activity. 
 
It is estimated that there are some 10-100 million species of organisms living on earth. 
Higher plants form a small group of some 250 000 species of which only 6% have been 
investigated for biological activity and 15% for their chemical constituents. To date, some 
139 000 secondary metabolites have been isolated, the major groups being alkaloids and 
terpernes. Thus, we have only scratched the surface of this wonderful resource of natural 
chemicals with its vast potential for the development of new drugs for medicinal use 
(Heinrich et al., 2004). 
 
1.2. THE GENUS HERMANNIA:  
 1.2.1. Selection, description and distribution 
Hermannia is a genus of the subfamily Byttnerioideae and tribe Hermanieae of the family 
Malvaceae (previously Sterculiaceae).There are about 180 species of Hermannia found 
worldwide. Eleven species occur in tropical Africa, three in America, one or more in 
Australia and about 162 species in Southern Africa (Leistner, 2000).  
The genus was introduced by Tournefort, but as taxonomic priority is conventionally 
started with Linnaeus's Species Plantarum of 1753, it is usually ascribed to Linnaeus. 
Tournefort named the genus after Paul Hermann who was a professor of Botany at Leyden 
in the latter part of the seventeenth century. 
The wide diversity of species in a restricted geographical region is suggestive of a recent 
origin and diversification of the species. The lack of reported variation in chromosome 
counts may be further evidence in favor of this interpretation, or may reflect a limited 
sampling of the species of the genus. On the other hand the genus seems less derived than 
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the other genera of the tribe (e.g. in the presence of 5-locular ovules with pluri-ovulate 
locules, which is a widespread condition in Byttneroideae, whereas the other genera show 
reduction in both the number of locules and ovules). Combining this observation with the 
disjunctive distribution suggests that it may be worth testing the hypothesis that 
Hermannia is polyphyletic (Hinsley, 2003). 
These are generally herbs, shrublets or undershrubs and are frequently stellate-pubescent, 
sometimes glandular. Leaves are entire, toothed or pinnatifid with stipules often 
foliaceaous. Flowers are axillary and solitary or binate or in terminal pseudoracemes or 
panicles. Calyx is 5-lobed and the tube globose to campnulate. Petals number five and are 
obovate or oblong, sessile or clawed, spirally twisted; claw with infolded margin. Five 
stamens occur opposite petals, and are either longer or shorter than the ovary. The 
filaments are connate at the base, and are sometimes almost free and linear with broad 
membraneous wings or are somewhat cruciform. Anthers are mostly lanceolate, slightly or 
distinctly two-lobed at the apex. Ovary is sessile or shortly stalked, five–lobed, five-
locular, with few to many ovules in each locule and is hairy. The five styles that occur are 
capitate. Fruit are five-locular, loculicidal capsule and are sometimes horned. Seeds are 
reniform, and usually ribbed (Leistner, 2000). 
 
1.2.2. Traditional uses and extent of usage 
The genus Hermannia has been utilized traditionally by a diversity of people such as the 
European, Tswana, Kwena, Southern Sotho, Xhosa and Zulu for a wide variety of uses 
such as fever, cough, respiratory diseases such as asthma, wound plaster, burns, 
stomachache, purgative, diaphoretic, heartburn, flatulence in pregnant women, colic, 
hemorrhoids as well as syphilis and eczema. In addition specific species of Hermannia that 
have been chosen to be researched have the following uses: 
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Hermannia incana:  
The Xhosa use a decoction of the root for dysuria. The decoction is blue if boiled in an iron 
vessel and greenish in a “tin” one and becomes starchy when cold. 
Hermannia salviifolia: 
This plant is used to make a tea with aromatic properties and a decoction of the root is an 
old-fashioned European household remedy for fits. An ointment made from the plant 
together with Losbostemon fruticosus and Psoralea decumbens is an old Cape remedy for 
“roos” (erysipelas or eczema). 
 
Hermannia cuneifolia: 
The Europeans apply and infusion or a decoction of this plant to sores and take the 
preparation internally (Watt and Breyer-Brandwijk, 1962). 
Hermannia althaeifolia: 
This plant was cultivated in Europe during the 18th century and was used medicinally as an 
aromatic tea against syphilis (Shearing, 1997). 
 
1.2.3. Previous research conducted on the genus 
Most ethnobotanical literature refers to the extensive traditional use of Hermannia and, 
thus, it is remarkable that limited research has been conducted on this genus implying that 
very little information is available on the chemical constituents, pharmacology and toxicity 
of Hermannia. Two papers have been published regarding the antimicrobial and anti-
inflammatory activity as well as the antimalarial activity of one species of Hermannia i.e. 
H. depressa (Reid et al., 2005 and Clarkson et al., 2004). Since this is the only species of 
Hermannia to be investigated, this pioneer evaluation of the possible activity is necessary 
to gauge the potential pharmacological use and chemical composition of this genus.  
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1.3. RATIONALE: 
1.3.1. Choice of Hermannia species as a research topic 
It is unlikely that the ethnic population of Southern Africa would describe the various and 
extensive uses for this genus if the plants did not possess some biological activity and it 
would be interesting to note the possible correlation between the traditional use of the 
genus and the actual biological activity. In addition, since this is, surprisingly, one of the 
first studies to be conducted on this genus, isolation of any active compounds could 
produce interesting and biologically active compounds that may play an important role in 
the treatment of diseases. 
 
1.3.2. Choice of the studied biological activities 
There may be correlation between traditional usage and pharmacological action, such as 
isolation of anti-pyretic principals from a ‘fever’ remedy, but even so, it may be different 
from our expectations. Therefore, extracts of plants based on traditional usage should not 
only be tested for the activity expected, but should also be subjected to a battery of tests, 
since some important modern drugs have been developed from plants which have been 
used for a different purpose entirely (Heinrich et al., 2004). Thus, four activities were 
assayed, all related to the possible activity indicated by the traditional use. In addition, 
toxicity of the plants species was also determined. 
 
The treatment of respiratory diseases, wounds, burns, dysuria, piles as well as suppurating 
wounds suggest that the plants my contain compounds with antimicrobial activity as 
infection plays an important role in the promotion of these disease states. Thus assessment 
of this activity against a diversity of pathogens is essential to obtain the scope of activity 
portrayed by the species. 
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In addition, inflammation is a significant factor in the above-mentioned diseases as it is the 
initial response to tissue injury. The treatment of these disease states may thus involve 
some form of anti-inflammatory activity and therefore to obtain an idea of the method in 
which these species function in the treatment of disease, an anti-inflammatory assay is 
necessary.  
 
The role of free radical reactions in biology has become an area of intense interest. It is 
generally accepted that free radicals play an important role in the development of tissue 
damage and pathological events in living organisms and thus there is an increased interest 
in the natural antioxidants contained in medical and dietary plants, which are candidates 
for the prevention of oxidative damage (Velázquez et al., 2003). Considering the extensive 
use of the genus Hermannia to treat a number of diseases for which free radicals may act 
as a primer, it is necessary to establish the free radical scavenging activity of the plant 
extracts. 
 
Research previously conducted on related genera such as Melochia reported the presence 
of alkaloids within that genus (Kapadia et al., 1977) and potentially may occur in the 
various species of Hermannia. Alkaloids are most often associated with antimalarial 
activity and thus this activity was assessed. In addition some species are used to treat 
‘fever’ which in many areas especially in Africa, may be related to a malarial infection 
(Addae-Kyereme et al., 2001). 
 
During the course of their evolution, many plant species have been protected by their 
ability to accumulate toxic compounds (Cotton, 1996). The quantity of these toxins found 
in the plants and their ability to cause damage to cells and cell death is an important factor 
to be assessed. A plant may have potent biological activity but should it also prove to be 
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highly toxic, it cannot be used to any benefit in humans and thus, toxicity testing is 
essential. 
 
1.4. OBJECTIVES OF THE STUDY: 
The study has been completed with the following objectives: 
• To phytochemically characterize the species using thin layer chromatography and 
HPLC/UV.  
• To isolate and identify of phytochemicals from lead crude plant extracts using 
column chromatography, thin layer chromatography, nuclear magnetic resonance 
spectroscopy and mass spectroscopy. 
• To screen selected species for antibacterial activity using minimum inhibitory 
concentrations, the death kinetics assay and bioautographic assays. 
• To screen selected species for antioxidant activity using DPPH and ABTS 
antioxidant assays and to determine the concentration of selected species to reduce 
50 % of free- radicals (IC50). 
• To screen of selected species for anti-inflammatory activity using the 5-
lipoxygenase enzyme assay and to determine the concentration of species to inhibit 
50 % of 5-lipoxygenase activity (IC50).  
• To screen of selected species for anti-malarial activity using titrated hypoxanthine 
incorporation assay. 
• To establish the potential toxicity that is portrayed by these plants and to relate the 
toxicity to biological activity. 
• To provide a scientific basis for the traditional use and indigenous knowledge 
which has developed around this genus. 
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CHAPTER 2: STUDIED SPECIES, PLANT COLLECTION AND 
PREPARATION OF SAMPLES 
 
2.1. STUDIED SPECIES: 
There are approximately 180 species of Hermannia worldwide of which about 162 species 
occur in Southern Africa (Leistner, 2000). Ten species were originally chosen for 
investigation based on the extent of traditional use as well as availability and accessibility 
for collection of the plant material. Later two species were added to the investigation as 
they became available. A collecting permit was obtained from Cape Nature Conservation. 
 
2.1.1. Hermannia althaeifolia  
This plant is also known by the vernacular names ‘Wolhaar Poproos’, ‘Bokkiesblom’ and 
‘Pokkiesblom’. It is a shrublet with soft hairy branches. The leaves are wrinkled and 
roughly toothed and are softly hairy. The stipules are large and leaf-like. Flowers occur in 
axillar clusters and are bright orange-yellow with a swollen, hairy calyx (Fig 2.13). 
Flowering occurs from August to March. The plants occur on clay flats and slopes or along 
sandy watercourses from Namaqualand to Uniondale. They are perennial plants that may 
grow up to 50 cm in height. They are sometimes grazed (Shearing, 1997) Fig 2.1 indicates 
the distribution of this species in South Africa. 
 
Fig. 2.1: Distribution map of H. althaeifolia. (All distribution maps purchased and 
included with permission from the South African National Biodiversity Institute) 
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2.1.2. Hermannia cuneifolia 
 
Also known as ‘Agtdaegeneesbos’, this plant is an aromatic shrub that may grow up to 50 
cm in height. The leaves are wedge-shaped and are slightly hairy. It has bright yellow to 
orange flowers that are pendulous (Fig 2.14). They are plants that are drought resistant and 
well grazed by animals. They occur throughout the Cape and one locality in Lesotho in 
seasonal streams and wide range of habitats (Shearing, 1997) (Fig 2.2).  
 
Fig. 2.2: Distribution map of H. cuneifolia. 
 
2.1.3. Hermannia flammula 
The plant is also called ‘Poprosie’ by the local population. It is a shrublet which grows up 
to 250-900mm in height. The flowers are red in color (Fig 2.15) and the plants occur on the 
lower slopes of hills. The plants occur in regions from Caledon to Uniondale as well as the 
Little Karoo (Fig 2.3). 
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Fig. 2.3: Distribution map of H. flammula. 
 
2.1.4. Hermannia holosericea 
This is a velvety shrub that grows to 0.3 to 1.2 m in height. The flowers are yellow. The 
plants grow on coastal limestone to middle inland slopes from Bredasdorp and Montagu to 
Oudshoorn as well as Mossel Bay to Uitenhage in the Eastern Cape (Fig 2.4). 
 
Fig. 2.4: Distribution map of H. holosericea. 
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2.1.5. Hermannia incana 
The plant is a grey-leafed shrub which grows up to 2 m in height. The flowers are yellow 
in color (Fig 2.16). The plants grow on the dry lower to middle slopes in regions between 
Worcester to Outshoorn as well as the Peninsula to George in the Karoo (Fig 2.5). 
 
Fig. 2.5: Distribution map of H. incana. 
 
2.1.6. Hermannia involucrata 
This is a golden-yellow shrub that may grow to over 1 m. It bears flowers that are yellow 
to orange in color (Fig 2.17). They grow on shaded lower slopes and occur at Ladismith, 
Humansdorp and Uniondale (Fig 2.6). 
 
Fig. 2.5: Distribution map of H. involucrata. 
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2.1.7. Hermannia lavandufolia 
This plant is a spreading shrublet that has velvety grey leaves. It grows to between 0.3 to 1 
m and has flowers that are colored yellow to orange (Fig 2.18). They occur on the lower 
coastal slopes in the region of Caledon to Mossel Bay (Fig 2.7). 
 
Fig. 2.7: Distribution map of H. lavandufolia. 
 
2.1.8. Hermannia muricata 
Hermannia muricata is a flexuose shrublet which grows up to 200 mm in height. The plant 
bears flowers that yellow to orange in color (Fig 2.19). They occur in the river valleys from 
Clanwilliam, Piketberg, Worcester, to Uniondale basically the Karoo and Namaqualand 
regions (Fig 2.8). 
 
Fig. 2.8: Distribution map of H. muricata. 
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2.1.9. Hermannia saccifera 
Also known as ‘Komynbossie’, this is an erect or sprawling woody shrublet that may grow 
up to 300 mm. The flowers are yellow (Fig 2.20) and the plants occur on the lower coastal 
slopes of the region Bredasdorp to Uitenhage (Fig 2.9). 
 
Fig. 2.9: Distribution map of H. saccifera 
 
2.1.10. Hermannia salviifolia 
Hermannia salviifolia is a variable shrub which has roughly pubescent leaves and may 
grow to over 1 m in height. It has flowers that are a yellow-orange color. The plants occur 
on the coastal flats or lower slopes of the region Peninsula to Port Elizabeth (Fig 2.10). 
 
Fig. 2.10: Distribution map of H. salviifolia 
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2.1.11. Hermannia scabra 
This is an erect or spreading shrublet that grows up 600 mm. The flowers are yellow in 
color or may be a fading reddish color. They occur on the middle slopes of hills from 
Gifberg to Clanwilliam as well as Malmesbury (Fig 2.11). 
 
Fig. 2.11: Distribution map of H. scabra 
 
2.1.12. Hermannia trifurca 
This is a twiggy shrub that grows up to 1 m. The flowers are a pink to purple color. The 
plants occurs on the flats or lower slopes in areas from Clanwilliam to Malmesbury as well 
as Ceres, Worcester and in the Namaqualand as well as Namibia (Bond and Goldblatt, 
1984) (Fig 2.12). 
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Fig. 2.12: Distribution map of H. trifurca 
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             Fig. 2.13: H. althaeifolia                                      Fig. 2.14: H. cuneifolia 
 
           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
             Fig. 2.15: H. flammula                                         Fig. 2.16: H. incana 
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           Fig. 2.17: H. involucrata                                     Fig. 2.18: H. lavandufolia 
 
          
            Fig. 2.19:  H. muricata                                      Fig. 2.20: H. saccifera 
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2.2. COLLECTION OF PLANT MATERIAL 
Fresh plant material of selected Hermannia species was collected from natural populations 
in the Cape region of South Africa (Table 2.1). The taxonomy was confirmed by botanists 
at the National Botanical Institute (NBI) in Pretoria, South Africa and voucher specimens 
have been maintained at the Department of Pharmacy and Pharmacology at the University 
of the Witwatersrand in Johannesburg.   
Table 2.1: Selected species of Hermannia studied 
Species Locality Vegetation 
Type 
Date of 
Collection 
Voucher 
Number 
H. althaeifolia Uniondale, in 
Langkloof near 
turnoff to Daskop 
Fynbos 06/11/2003 2834 
H. cuneifolia De Rust, on hill 
south of town 
Renosterveld, 
Succulent 
Karoo 
05/11/2003 2828 
H. flammula Uniondale, in 
Langkloof near 
turnoff to Daskop 
Fynbos 06/11/2003 2832 
H. holosericea De Rust, on hill 
south of town 
Renosterveld, 
Succulent 
Karoo 
05/11/2003 2827 
H. incana De Rust, on hill 
south of town 
Renosterveld 05/11/2003 2829 
H. involucrata Uniondale, next to 
road near Daskop 
Renosterveld 06/11/2003 2831 
H. lavandufolia Oudsthoorn, 
northern end of 
Paerdepoort, near 
farm Heimersrivier. 
Succulent 
Karoo 
06/11/2003 2835 
H. muricata Uniondale, in 
Langkloof near 
turnoff to Daskop 
Fynbos 06/11/2003 2833 
H. saccifera Dysselsdorp, next 
to road near farm, 
Leenblad 
Renosterveld, 
Succulent 
Karoo 
06/11/2003 2830 
H. salviifolia Oudtshoorn, next to 
national road to 
George near 
Blossoms 
Succulent 
Karoo 
06/11/2003 2836 
H. scabra Farm Kersefontein, 
Darling district 
Fynbos 16/09/2004 AV 1165 
H. trifurca Farm Kersefontein, 
Darling district 
Fynbos 16/09/2004 AV 1166 
  
26 
2.3. PREPARATION OF SAMPLES: 
2.3.1. Process of extraction 
A thin layer chromatography plate indicated that leaves, flowers and stems contained 
similar compounds and hence, these parts were combined before crushing. Fresh plant 
material was dried through air drying. When plant material was completely dry, it was 
crushed into powder which was then used in various assays and preparative 
chromatography.  
 
To conduct assays on the crude extracts, the pulverized plant material was extracted (5 g) 
in a conical flask using the necessary solvent by adding approximately 50 ml of solvent to 
the flask and placing the flask in a water bath at 40° C for three hours after which the 
solvent was filtered off into a separate flask. This was repeated three times to maximize the 
extraction. The solvent was then evaporated utilizing a Büchi Rotavapor R-114 and the 
weight of the extract was obtained. These extracts were then diluted in suitable solvents 
specific for each assay to varying concentration and were thus utilized to determine the 
various biological activities. 
 
Isolation of compounds required a larger quantity of powdered plant material (500 g) 
which was extracted in a cylinder through which the solvent could be removed easily. 
Solvent was added to the crushed plant material and extracted for 48 hours during which 
the solvent was removed and fresh solvent added three times. The solvent was then 
evaporated using a Büchi Rotavapor R-114 and the weights of the extracts were 
determined.  
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CHAPTER 3: PHYTOCHEMICAL ANALYSIS 
  
3.1. INTRODUCTION: 
Chromatographic procedures are the most diverse and the most widely used techniques in 
fractionation of extracts. All chromatography relies on the differential distribution of 
compounds between two phases, one of which moves relative to the other. These phases 
are called the mobile and stationary phase, respectively. The mobile phase is a fluid, which 
can be either liquid, a gas, or a supercritical fluid. The stationary phase usually appears to 
be a solid consisting of fine particles (Houghton and Raman, 1998).  
 
Chromatography is a separation process. The analysis is accomplished by first separating a 
mixture into its individual components and then, monitoring these with a detector for 
quantitative determination and/or qualitative identification. Optimizing the 
chromatographic process implies generating sufficient resolution between adjacent 
components as quickly as possible. The individual constituents of a mixture are separated 
as a result of their different physical and chemical interactions with the mobile phase (the 
solvent) and with the stationary phase (the column packing) (Henschen et al., 1985). 
 
Chromatography is based on the act that a dynamic equilibrium is established between the 
concentration of a solute in two phases. This dynamic equilibrium consists between 
molecules of the solutes continually passing between the two phases. At any one time the 
concentration ratio, i.e. ratio of number of molecules in each phase, is constant. However, 
each molecule spends time in both phases and the proportion of time spent in a phase 
depends on the relative attractions of the substance for the two phases. The concentration 
ratio at equilibrium is called the distribution coefficient and the name for the attraction for 
any phase is called the affinity, i.e. a compound that moves more slowly is said to have a 
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higher affinity for the stationary phase than the one that moves more quickly (Houghton 
and Raman, 1998).  
Thin layer chromatography (TLC) is a solid-liquid technique in which the two phases are a 
solid (stationary phase) and a liquid (moving phase). Solids most commonly used in 
chromatography are silica gel (SiO2 x H2O) and alumina (Al2O3 x H2O). Both of these 
adsorbents are polar, but alumina is more so. Silica is also acidic. Alumina is available in 
neutral, basic, or acidic forms. TLC is a sensitive, fast, simple, and inexpensive analytical 
technique. It is a micro technique; as little as 10-9g of material can be detected, although 
the sample size is from 1 to 100x10-6 g. TLC involves spotting the sample to be analyzed 
near one end of a sheet of glass or plastic that is coated with a thin layer of an adsorbent. 
The sheet, which can be the size of a microscope slide, is placed on end in a covered jar 
containing a shallow layer of solvent. As the solvent rises by capillary action up through 
the adsorbent, differential partitioning occurs between the components of the mixture 
dissolved in the solvent the stationary adsorbent phase. The more strongly a given 
component of a mixture is adsorbed onto the stationary phase, the less time it will spend in 
the mobile phase and the more slowly it will migrate up the plate. The following are some 
common uses of TLC: 
1. To determine the number of components in a mixture.  
2. To determine the identity of two substances.  
3. To monitor the progress of a reaction.  
4. To determine the effectiveness of a purification.  
5. To determine the appropriate conditions for a column chromatographic separation.  
6. To monitor column chromatography (Fried and Sherma, 1996) 
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A large number of spray reagents have been produced which when applied to a layer forms 
colors from colorless substances. Some of the spray reagents are very specific, but many 
others will react with a broadly based type of compound. Thus these spray reagents due to 
the color reactions may be useful in determining the nature of the compounds forming 
zones on the TLC plate (Houghton and Raman, 1998). 
High performance liquid chromatography (HPLC) uses high pressure to force eluent 
through a closed column packed with micron-size particles that provide exquisite 
separations of picograms to micrograms of analyte. Essential components include a solvent 
delivery system, a sample injection valve, a detector, and a recorder or computer to display 
results. If a solute can diffuse rapidly between the mobile and stationary phases, then plate 
height is decreased and resolution increases. In liquid chromatography, we increase the rate 
of mass transfer by reducing the dimensions of the stationary particles, thereby reducing 
the distance through which solute must diffuse in both phases (Harris, 1995).  
 
The detector for an HPLC is the component that emits a response due to the eluting sample 
compound and subsequently signals a peak on a chromatogram. It is positioned 
immediately posterior to the stationary phase in order to detect the compounds as they 
elute from the column. The bandwidth and height of the peaks may usually be adjusted and 
the detection and sensitivity parameters may also be controlled. There are many types of 
detectors that can be used with HPLC such as Refractive Index, Ultra-violet, Fluorescent, 
Radiochemical, Electrochemical, Near-Infra Red, Mass Spectroscopy, Nuclear Magnetic 
Resonance, and Light Scattering. 
 
Ultra-violet detectors measure the ability of a sample to absorb light. UV detectors have a 
sensitivity to approximately 10-8 or 10-9 gm/ml. This can be accomplished at one or several 
wavelengths such as by utilizing Fixed Wavelength, Variable Wavelengths, or Diode 
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Array detectors. Photodiode Array detectors can be used to measure and detect samples 
over the entire UV to visible spectrum. These detectors record the entire spectrum at once 
in a fraction of a second. They are highly beneficial tools in identification and analysis of a 
sample compound (Parriott, 1993) 
  
HPLC is unquestioningly the most widely used of all of the analytical separation 
techniques. The reasons for the popularity of the method are its sensitivity, its ready 
adaptability to accurate quantitative determination, its suitability for separating nonvolatile 
species or thermally fragile ones, and above all, its widespread applicability to substances 
that are of prime interest to industry, to many fields of science, and to the public. Examples 
of such materials include amino acids, proteins, nucleic acids, hydrocarbons, 
carbohydrates, drugs, terpenoids, pesticides, antibiotics, steroids, metal-organic species, 
and a variety of inorganic substances (Skoog and Leary, 1992). High performance liquid 
chromatography is now a firmly established separation technique which can be used in a 
variety of ways in a laboratory dealing with plant products, both for preparative and 
analytical purposes (Linskens and Jackson, 1987).  
 
3.2. METHOD: 
3.2.1. Thin layer chromatography 
Plant extracts of ten species [chloroform: methanol (1:1)] as well as two isolated 
compounds were utilized for TLC analysis. Analysis of H. scabra and H. trifurca were not 
conducted as these species were added to the investigation at a later stage. All samples 
were made up to concentrations of 50 mg/ml in chloroform: methanol (1:1). Solutions of 
samples (2 µl in volume) were applied to 0.2 mm silica-gel, aluminium-backed TLC plates 
(Macherey-Nagel Art. 818133) after which the plates were developed in one of the 
following TLC systems: 
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• TLC 1: methanol: water: ethyl acetate (1.65: 1.35: 10) 
• TLC 2: toluene: ethyl acetate (6:4) 
• TLC 3: toluene: dioxan: ethyl acetate (9: 2.5: 1) 
Plates were developed up to 9 cm. Thereafter the plates were dried and examined under 
UV light (UV254nm and UV365nm) after which they were sprayed with 
anisaldehyde/sulphuric acid spray reagent (anisaldehyde: conc. H2SO4: methanol [1:2:97]), 
using an atomizer. Plates were heated for 5-10 min at 100°C.The spray reagent enabled 
visible evaluation of the plates.  
 
3.2.2. HPLC/UV 
HPLC/UV was overseen by Dr Paul Steenkamp from the Forensic Toxicology Research 
Unit, Forensic Chemical Laboratory in Johannesburg. A Waters 2690 HPLC System 
(Phenomenex Aqua C18 column, 250 x 2.1 mm) equipped with a 996 photodiode array 
(PDA) detector was used. The mobile phase which was added over time at a flow rate of 
0.2 ml/min, was a 10% acetonitrile in 10 µM aqueous formic acid solvent. The ratio was 
changed through a linear gradient to 90 % acetonitrile in 10 % 10 µM aqueous formic acid 
at 40 min. This ratio was maintained for 10 min after which the solvent ratio was changed 
back to the original starting solution. HPLC profiles were analyzed by convolution of 
retention times and UV profiles using Empower® software. 
 
3.3. RESULTS:  
Thin-layer chromatography of ten species when examined under UV light indicated few 
compounds present. However, anisaldehyde spray reagent indicated that many compounds 
are present in the extract that had not been visible under UV light. Plates developed in TLC 
1, 2 (Fig. 3.1. and Fig. 3.2) and 3 (Fig. 3.3.) indicated many similarities in the 
phytochemical composition of all ten species. However, the TLC plates also indicate a 
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distinct difference being portrayed by H. saccifera, which when compared to the other 
species being investigated, indicates anomalous compounds which are not present in the 
other species. This chemical diversity is evident in all TLC systems utilized. In addition, 
further TLC analysis indicated that β-sitosterol and lupeol are present in the ten species 
investigated (Fig. 3.4. and Fig. 3.5.)   
 
Fig. 3.1: TLC plate of ten species of Hermannia developed in TLC: 1. The distinct and 
characteristic profile of H. saccifera is shown in the black box. 
1 2 3 4 5 6 7 8 9 10 
Legend: For all 
TLC Plates 
1 - H. flammula 
2 – H. holosericea 
3 – H. cuneifolia 
4 – H. althaeifolia 
5 – H. lavandufolia 
6 – H. saccifera 
7 – H. salviifolia 
8 – H. involucrata 
9 – H. incana 
10 – H. muricata 
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Fig. 3.2: TLC plate of ten species of Hermannia developed in TLC: 2. The area boxed-in 
in red refers to similar compounds present in all species of Hermannia being investigated. 
The black box refers to H. saccifera. 
 
Fig. 3.3: TLC plate of ten species of Hermannia developed in TLC: 3. Species show 
distinct similarities with only H. saccifera appearing to contain compounds not present in 
the other species studied. 
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Fig: 3.4. TLC plate indicating the presence of β-sitosterol in ten species of Hermannia 
being investigated. 
 
Fig. 3.5: TLC plate indicating the presence of lupeol in ten species of Hermannia being 
investigated.  
 
Fig 3.18 shows the HPLC profiles for all twelve selected species. Some similarities are 
indicated from these, which were confirmed using retention times and UV profiles for 
specific compounds. Tables 3.1 - 3.13 indicate the retention times and percentage area 
obtained for peaks found in each of the species analyzed as well as the isolated compound 
investigated. 
Β-sitosterol 
lupeol 
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Fig. 3.6: HPLC profile for H. althaeifolia. 
Table 3.1: HPLC retention time and percentage area for peaks from H. althaeifolia. 
 
Retention Time Absorbance maxima (nm) % Area 
3.8 201.6 and 207.4 3.0 
13.2 202.8, 226.2, 285.1 and 336.1 2.9 
13.5 201.6 and 278.0 28.8 
14.5 207.4 and 278 37.6 
15.0 201.6 and 278.0 10.8 
15.3 202.8 and 281.5 3.0 
15.5 201.6 and 279.2 10.8 
18.0 201.6 and 278.0 3.3 
27.0 229.7, 266.2 and 313.5 2.4 
 
 
Fig. 3.7: HPLC profile for H. cuneifolia. 
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Table 3.2: HPLC retention time and percentage area for peaks from H. cuneifolia. 
 
Retention Time Absorbance maxima (nm) % Area 
3.9 201.6 and 207.4  2.6 
9.92 209.8, 260.3 and 296.9 7.0 
13.1 202.8 and 279.2 1.1 
13.5 201.6 and 278.0 9.3 
13.9 201.6 and 279.2 1.6 
14.5 205.1 and 278.0 17.7 
14.9 202.8 and 279.2 5.5 
15.2 202.8 and 279.2 5.7 
15.7 202.8 and 279.2 4.2 
16.0 202.8 and 279.2 2.1 
16.2 202.8 and 279.2 2.0 
16.5 201.6 and 279.2 2.7 
20.5 203.9 and 278.0 1.8 
20.6 202.8 and 278.0 2.7 
20.7 201.6 and 278.0 2.6 
20.9 202.8 and 272.1 2.5 
45.159 228.5, 274.4, 324.2 and 408.8 28.2 
 
 
Fig. 3.8: HPLC profile for H. flammula. 
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Table 3.3: HPLC retention time and percentage area for peaks from H. flammula. 
 
Retention Time Absorbance maxima (nm) % Area 
3.9 207.4 and 307.6 2.8 
13.8 202.8, 226.2, 283.9 and 336.1 5.4 
14.1 201.6 and 278.0 14.2 
14.8 201.6 and 274.4 2.7 
15.2 206. and 278.0 37.3 
15.8 202.8, 275.6 and 369.2 5.8 
16.4 203.9 and 275.6 2.3 
20.2 351.6 6.2 
20.5 201.6, 285.1 and 327.8 3.0 
21.0 203.9 and 278.0 3.46 
28.3 267.4 and 313.5 8.7 
36.7 229.7 and 276.8 8.6 
 
 
 
Fig. 3.9: HPLC profile for H. incana. 
Table 3.4: HPLC retention time and percentage area for peaks from H. incana. 
 
Retention Time Absorbance maxima (nm) % Area 
3.8 201.6 and 207.4 nm 2.1 
12.2 207.4 and 270.9 6.5 
13.1 202.8, 283.9 and 336.1 2.9 
13.5 203.9 and 278.0 16.0 
14.0 202.8 and 279.2 3.9 
14.5 206.3 and 278.0 22.7 
14.9 202.8 and 278.0 8.9 
15.3 202.8 and 279.2 8.8 
15.7 202.8 and 279.2 5.4 
16.0 202.8  and 279.2 3.3 
20.5 202.8 and 278.0 10.4 
27.0 266.2 and 313.5 5.4 
27.7 228.5, 267.4 and 312.3 3.2 
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Fig. 3.10: HPLC profile for H. involucrate. 
Table 3.5: HPLC retention time and percentage area for peaks from H. involucrata. 
 
Retention Time Absorbance maxima (nm) % Area 
3.8 201.6 and 207.4 11.1 
11.8 219.1 and 378.0 3.0 
13.5 202.8 and 278 12.6 
14.5 202.8 and 278 24.3 
14.9 282.7 and 326.6 5.3 
15.3 201.6 and 278.0 2.9 
16.6 201.6, 256.7 and 352.8 2.7 
26.9 266.2 and 313.5 5.9 
40.7 241.4 and 324.2 13.4 
50.3 216.8, 241.4 and 323.0 18.4 
 
 
Fig. 3.11: HPLC profile for H. holosericea. 
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Table 3.6: HPLC retention time and percentage area for peaks from H. holosericea. 
Retention Time Absorbance maxima (nm) % Area 
3.9 206.3 2.5 
5.3 220.3 and 282.7 4.7 
10.4 206.3 and 269.7 14.6 
11.7 219.1 and 278.0 2.5 
12.2 206.3 and 269.7 6.8 
12.5 202.8 and 282.7 3.9 
13.0 203.9, 225.0, 256.7, 287.4, 319.4 23.3 
14.2 203.9 and 278.0 5.8 
14.5 202.8and 278.0 2.6 
19.8 295.7 and 331.3 4.2 
20.4 278.0 16.9 
21.6 206.3, 255.6 and 293.4 2.2 
27.0 266.2 and 313.5 9.5 
 
 
Fig. 3.12: HPLC profile for H. lavandufolia. 
Table 3.7: HPLC retention time and percentage area for peaks from H. lavandufolia. 
 
Retention Time Absorbance maxima (nm) % Area 
3.8 201.6 and 207.4 3.8 
10.2 201.6 and 289.8 34.0 
11.8 203.9 and 279.2 1.4 
12.0 201.6 and 278.0 4.2 
12.6 202.8 and 275.6 2.4 
13.1 202.8 and 278.0 16.4 
13.5 202.8 and 278.0 8.2 
14.5 202.8 and 278.0 15.7 
15.0 203.9 and 278.0 2.3 
17.7 202.8, 256.7 and 354.0 1.3 
20.5 265.0 and 343.2 1.3 
20.9 203.9, 254.4 and 354.0 2.6 
21.6 327.8 2.9 
50.4 216.8, 241.4 and 323.0 2.7 
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Fig. 3.13: HPLC profile for H. muricata. 
Table 3.8: HPLC retention time and percentage area for peaks from H. muricata. 
Retention Time Absorbance maxima (nm) % Area 
3.6 207.4 3.8 
3.8 207.4 and 278.0 23.0 
4.6 207.4 4.9 
10.5 207.4 and 278.0 3.5 
11.7 219.1 and 278.0 3.5 
13.2 203.9, 226.2, 256.7, 278.4, 325.4 5.2 
13.6 201.6 and 279.2 13.2 
14.6 203.9 and 278.0 31.7 
15.1 201.6 and 376.4 1.8 
27.1 266.2 and 313.5 8.8 
 
 
Fig. 3.14: HPLC profile for H. saccifera. 
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Table 3.9: HPLC retention time and percentage area for peaks from H. saccifera. 
 
Retention Time Absorbance maxima (nm) % Area 
3.8 201.6 and 207.4 1.0 
12.3 207.4 and 267.4 1.0 
12.6 203.9 and 278.0 1.0 
13.5 202.8 and 278.0 13.1 
14.0 201.6 and 279.2 2.1 
14.5 207.4 and 278.0 15.3 
14.9 201.6 and 278.0 6.6 
15.3 201.6 and 278.0 5.4 
15.7 201.6 and 280.3 3.6 
16.1 201.6, 255.6 and 354.0 1.9 
18.0 202.8 and 278.0 1.5 
19.1 203.9, 255.6 and 354.0 1.9 
20.5 202.8, 268.5 and 356.3 31.5 
29.4 201.6, 293.4 and 336.1 2.3 
32.2 278.0 and 330.1 (Flavonoid) 4.3 
32.7 278 and 336.1  (Flavonoid) 3.5 
43.0 292.2 2.4 
45.6 260.3 1.5 
 
 
Fig. 3.15: HPLC profile for H. salviifolia. 
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Table 3.10: HPLC retention time and percentage area for peaks from H. salviifolia. 
 
Retention Time Absorbance maxima (nm) % Area 
3.2 201.6 and 283.9 1.2 
3.8 206.3 and 278.0 22.7 
4.6 207.4 2.4 
11.7 219.1 and 278.0 0.8 
12.3 206.3 and 268.5 0.4 
13.0 222.7 and 275.6 0.8 
15.6 206.3 and 343.2 0.9 
27.0 266.2 and 313.5 14.8 
27.8 266.2 and 312.3 1.6 
30.3 267.4 and 312.3 0.3 
40.8 216.8, 241.4 and 323.0 13.3 
50.3 216.8, 241.4 and 323.0 40.2 
 
 
Fig. 3.16: HPLC profile for H. scabra. 
Table 3.11: HPLC retention time and percentage area for peaks from H. scabra. 
 
Retention Time Absorbance maxima (nm) % Area 
3.9 202.8 and 259.1 40.7 
5. 259.1 7.4 
8.0 207.4 5.2 
11.9 218.0 and 278.0 12.2 
13.4 206.3, 285.1 and 327.8 2.1 
14.8 206.3, 280.3 and 323.0 2.5 
22.3 205.1 and 274.4 2.4 
27.1 210.9, 266.2 and 313.5 2.7 
35.1 235.6 4.5 
36.0 234.4 2.9 
40.4 237.9 3.3 
44.7 267.4, 331.3, 446.1 and 475.1 5.2 
49.2 219.1, 241.4 and 323.0 8.5 
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Fig. 3.17: HPLC profile for H. trifurca. 
Table 3.12: HPLC retention time and percentage area for peaks from H. trifurca. 
 
Retention Time Absorbance maxima (nm) % Area 
3.6 265.0 5.8 
4.0 205.1 4.4 
10.2 202.8 and 289.8 12.7 
12.4 206.3 and 269.7 8.0 
14.1 201.6 and 266.2 7.0 
14.3 201.6 and 265.0 9.3 
16.5 206.3 and 274.4 3.6 
18.3 202.8 and 276.8 8.2 
19.5 247.3 24.4 
20.1 206.3 and 336.1 5.3 
20.4 205.1 and 243.8 6.9 
32.6 234.4 and 331.3 3.8 
 
Table 3.13: HPLC retention time and percentage area for peaks of isolated flavones. 
 
Compounds Retention Time Absorbance maxima (nm) % Area 
Compound 2 31.9 278.0 and 334.9 (Flavone) 43.0 
Compound 3 32.5 278.0 and 336.1 (Flavone)  
 
Peak analysis indicates that similar compounds are present in certain species. H. 
althaeifolia, H. cuneifolia, H. incana, H .involucrata, H. lavandufolia, H. saccifera and H. 
scabra all indicate a compound with the retention time of approximately 3.8 min which 
corresponds to the UV absorbance with maxima at 201.6 and 207.4 nm.  In addition, H. 
involucrata, H. lavandufolia, H. saccifera and H. scabra contain a compound with 
retention time of approximately 13.5 min and the absorbance maxima of 202.8 and 278 
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nm. H. involucrata and H. lavandufolia indicate a compound with the retention time of 
14.5 and absorbance maxima at 202.8 and 278 nm. H. althaeifolia and H. saccifera contain 
a compound, retention time 14.5 min and absorbance maxima at 207.4 and 278 nm. 
 
H. saccifera alone portrays two compounds with retention times of 32.2 and 32.7 nm with 
maxima at 278.0 and 330.1 nm as well as 278 and 336.1 nm respectively (Fig 3.19). These 
compounds appear to occur in this species only.  Analysis of flavone compounds isolated 
from H. saccifera occur at 31.9 and 32.5 min and indicate UV spectra that are very similar 
with peaks occurring at 278.0 and 334.9 nm and 278.0 and 336.1 nm respectively (Fig. 
3.20).  
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Fig. 3.18: HPLC profiles for all twelve species of Hermannia 
H. althaeifolia 
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Fig. 3.19: UV spectra of compounds present in H. saccifera with retention times of 32.269 
and 32.707 min. 
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Fig. 3.20: UV spectra for flavone compounds, cirsimaritin (1) and 5,8- dihydroxy-6,7,4’- 
trimethoxyflavone. 
 
3.4. DISCUSSION: 
Thin layer chromatography analysis provided some insight into the chemical composition 
of the ten species of Hermannia being investigated. The profiles viewed under UV light 
were conservative indicating that many compounds contained in the extract are poor 
chromophores and are thus, unable to absorb UV light. Spraying with anisaldehyde reagent 
provided better insight into the phytochemical complexity of the species. In addition, both 
1 2 
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isolated compounds (β-sitosterol and lupeol) could not be viewed under UV light while 
they were observed after spraying since they are also poor chromophores. 
 
Remarkable similarity between the various species being investigated was seen (Fig. 3.1., 
3.2. and 3.3.). This was confirmed in all TLC systems used.  Different solvent systems may 
be used for different classes of compounds based on the polarity of organic solvent being 
used (Ahmad and Beg, 2001), and thus, three different TLC systems were used. All three 
systems indicated the similarity of compounds present indicating that there are many 
different classes of common compounds that are present in the species being investigated, 
indicating the possible taxonomic importance of these similar compounds. 
  
TLC analysis, further, indicated that H. saccifera, while containing some of the common 
compounds, appears to be chemical anomalous to the other species. This distinct difference 
can bee seen in all TLC systems utilized. Further, antimicrobial bioautgrams indicated that 
these distinct compounds appear to be responsible for the good antimicrobial activity of H. 
saccifera, which is considerably greater than any of the other species (Chapter 5). Thus, 
isolation of these compounds was imperative to identify these interesting and possibly 
novel compounds that possessed promising biological activity. 
 
β-sitosterol and lupeol were also present in all species investigated. This is not an unusual 
occurrence since these compounds are common in the plant kingdom. However, they have 
been shown to possess some biological activity (Awad et al., 2004; Geetha and 
Varalakshmi, 2000; Ziegler et al., 2004) and thus, may contribute to the pharmaceutical 
significance of these plants 
 
The HPLC profiles appear to be very conservative and few compounds were detected 
through HPLC/UV. This suggests that many compounds contained within the plant are not 
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good chromophores i.e. that the compounds do not contain certain molecules that have the 
ability to absorb light. Thus, many interesting and possibly bioactive compounds would not 
have been detected and would, therefore, require further analysis. Isolation of compounds 
in Chapter 4 confirmed the presence of several compounds which are poor chromophores. 
 
Common compounds elute at retention time of 3.8, 13.5 as well as two compounds at 14.5 
min. The UV spectra obtained for these retention times confirm that these are similar 
compounds found in the different species. Although these compounds do not appear in all 
species, they may be present in trace amounts that would not have been detected on the 
HPLC/UV. These compounds may therefore be characteristic of the genus, thus indicating 
a chemotaxonomic potential for these compounds. 
 
H. saccifera has two peaks at retention times of 32.2 and 32.7 nm and λmax  at 278.0 and 
330.1 nm as well as 278 and 336.1 nm respectively. These λmax correspond with that 
suggested for flavones since typical flavone UV spectra exhibit two major absorption 
peaks in the region 240-400 nm (Mabry et al., 1970). This corresponds with the two 
flavone compounds isolated from H. saccifera as described in Chapter 4, namely 
cirsimaritin and 5,8- dihydroxy-6,7,4’- trimethoxyflavone. These peaks do not appear to 
occur in the other species being analyzed as can be seen in the HPLC profiles displayed in 
Fig 3.18.  
 
Considering the conservative nature of these HPLC profiles, it may be useful to conduct 
further HPLC analysis utilizing a different detector which would be able to analyze 
compounds that do not absorb UV light. One possible suggestion would be fluorescent 
detectors, which measure the ability of a compound to absorb then re-emit light at given 
wavelengths. Another detector that may be useful is a refractive index detector, which 
measures the ability of sample molecules to refract light (Parriott, 1993). Thus, although 
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the photodiode detector is a useful tool and is widely utilized, it is less useful in these 
plants as they do not contain many compounds that are good chromophores.  
 
3.5. CONCLUSION: 
TLC analysis has identified common compounds in the various species of Hermannia 
investigated which was further corroborated by the HPLC/UV profiles obtained. This 
aspect may be useful for taxonomic purposes for identification of species belonging to the 
genus, Hermannia. H. saccifera was shown to be chemically anomalous when compared to 
the other species, providing some insight into the extensive antimicrobial activity portrayed 
by the plant in comparison to the other selected species. H. saccifera, in addition, appears 
to be the only species investigated that contains the two isolated flavones, cirsimaritin and 
5,8- dihydroxy-6,7,4’- trimethoxyflavone. Further, lupeol and β-sitosterol are common 
compounds in all species and may contribute to the biological activity of these plants. The 
conservative nature of the HPLC/UV profiles suggests the presence of many compounds 
that are poor chromophores and therefore, further analysis must be conducted using 
different detectors to provide a greater insight of the phytochemical composition of this 
genus. 
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CHAPTER 4: ISOLATION OF COMPOUNDS FROM HERMANNIA 
SPECIES 
 
4.1. INTRODUCTION: 
Chemodiversity in Nature offers a valuable source for novel lead discovery. However, the 
discovery of drugs from Nature is complex. The biomass must be collected, dried and 
extracted into a suitable organic solvent to give an extract, which is then screened in a 
bioassay to assess biological activity. Active extracts are then fractionated using bioassay 
guided fractionation, in which chromatographic techniques are used to separate the extract 
into its individual components; the biological activity is checked at all stages until a pure 
active compound is obtained.  
 
Although biological activity testing is on-going, structure elucidation is necessary to 
determine the three-dimensional structure of the active compounds. This is done through a 
variety of techniques such as nuclear magnetic resonance spectroscopy and mass 
spectrometry. This will enable a literature search to be done to establish whether a 
compound is novel, what chemical class it belongs to and whether that type of compound 
has previously been reported to possess biological activity in the bioassay of interest or 
other bioassays (Heinrich et al., 2004). 
 
Nuclear magnetic resonance (NMR) is a spectroscopic technique that reveals information 
about the environment of magnetically active nuclei. Under proper conditions, such nuclei 
absorb electromagnetic radiation in the radio-frequency region governed by their chemical 
environment. This environment is influenced by chemical bonds, molecular conformations, 
and dynamic processes. By measuring the frequencies at which these absorptions occur 
and their strengths, it is usually possible to deduce facts about the structure of the molecule 
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being examined. NMR spectroscopy is commonly used in organic chemistry to elucidate 
molecular structures and conformations by studying 1H and 13C nuclei (Oehler, 2005).  
 
The combination of gas chromatography (GC) for separation and mass spectrometry for 
detection and identification of the components of mixtures of compounds is an important 
analytical tool in the research and commercial laboratory. Gas chromatography involves 
the absorptive interaction between the components with a column packing which leads to 
differential separation of the components of the mixture, which are passed in order through 
a detector flow cell. The mass spectrometer ionizes injected material and focuses these ions 
and their fragmentation products through a magnetic mass analyzer, and then collects and 
measures the amounts of each of the selected ions in a detector (McMaster and McMaster, 
1998). The data obtained when matched to a library and coupled with NMR forms an 
excellent basis for identifying compounds.   
 
It is important to note that, by following only a bioactivity-guided fractionation procedure, 
isolation of known plant constituents with recognized activity may occur. Furthermore, 
interesting lead compounds, which do not exhibit the tested activity, will simply be missed. 
Thus, in order to avoid the time-consuming isolation of known constituents, many 
identification techniques are used at the earliest stage of isolation to detect compounds 
with interesting structural features and to target their isolation.  
 
Given the complexity of the process described above, it is not surprising that many natural 
product leads fail to make their way onto the market. The expense, complexity and time of 
the natural drug lead process have influenced against natural products in the past, but the 
fact remains that natural products are a tried and tested source and there are many 
examples of compounds originally isolated from natural sources that are now produced 
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synthetically and are used pharmaceutically such as aspirin as well as many alkaloid 
compounds such as quinine, vinblastine and vincristine. 
 
The most important strength of natural products is their complex chemistry and structural 
diversity (Heinrich et al., 2004). The phytochemistry of the genus, Hermannia, has not 
previously been investigated and thus, an important resource for compound diversity 
remains unexplored. In addition to producing possible novel biologically active 
compounds, the plants may provide interesting structural diversity which may be utilized 
as lead compounds for further research and enhancement of biological activity. The good 
biological activity of H. saccifera as portrayed in the antimicrobial assays (Chapter 5) 
suggested that this plant may be a source of interesting biologically active compounds and 
hence it was chosen for compound isolation. In addition H. cuneifolia and H. salviifolia 
were chosen due to their extensive use in traditional medicine. 
 
4.2. METHOD: 
4.2.1. General Methods 
4.2.1.1. Nuclear Magnetic Resonance Spectroscopy (NMR Spectroscopy) 
Nuclear magnetic resonance spectroscopy was performed on a 400MHz Varian UNITY-
INOVA spectrophotometer. All spectra were recorded at room temperature in deuterated 
methanol (CD3OD) and deuterated chloroform (CDCl3). The chemical shifts were all 
recorded in parts per million (ppm) relative to TMS. For deuterated methanol, the spectra 
were referenced according to the central line δC = 49.0 and δH = 4.80 or δH = 3.30. For 
deuterated chloroform, the spectra were referenced according to the central line at δC = 
76.6 and δH = 7.24. 
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4.2.1.2. Mass Spectrometry (MS) 
The compounds were run on a Finnigan 1020 GC-MS spectrometer using either injection 
or solid probe methods. 
4.2.1.3. Optical Rotation 
Optical rotation was determined using a Jasco DIP-370 digital polarimeter. Samples were 
dissolved in chloroform to a concentration of 2 mg/ml. 
4.2.1.4. Infrared  
Infrared spectra were recorded on a Bruker Vector 22 infrared spectrometer using the thin-
film technique with chloroform as a solvent. 
 
4.2.1.5. General Chromatography 
Thin-layer and column chromatographic techniques were employed for the process of 
separation and isolation. Different sized columns were used in column chromatography, 
ranging from 1-5 cm in diameter, the size being dependant on the amount of sample 
available and the purification stage. Separation of the crude extract was carried out on a 
column using Macherey-Nagel Art. 815330 as well as Merck Art. 9385 silica gel. Final 
purification was found to be most successful when use was made of an open, 0.75 cm 
diameter Pasteur pipette column also packed with Merck Art. 9385 silica gel. All 
separations were carried out under gravity. Both the column and thin-layer 
chromatography made use of chemically pure hexane, dichloromethane, methanol, toluene 
and ethyl acetate (Rochelle Chemicals). Thin layer chromatography was carried out on 0.2 
mm silica-gel, aluminium-backed plates (Macherey-Nagel Art. 818133 and Merck Art. 
5554). The plates were analyzed under UV (254 and 366 nm) and then developed using 
anisaldehyde (Fluka) : conc. H2SO4 (Rochelle Chemicals) : methanol [1:2:97] spray 
reagent. 
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4.2.1.6. Dry Packing 
This procedure is employed for extracts that do not dissolve in a relatively non-polar 
solvent. These, generally, refer to methanol extracts as the extract dissolved in methanol 
cannot be loaded onto a column as separation would not occur. Hence, dry packing is 
undertaken. The extract is dissolved in a minimal amount of methanol, after which the 
extract is mixed with silica gel until the extract is absorbed onto the silica gel. The result is 
a fine, dry powdery extract which is left to dry and then loaded onto the column.  
 
4.2.2. Extraction and isolation of compounds from H. saccifera 
The powdered plant material (500 g) was extracted using acetone (1.5 L) over a period of 
48 hours at room temperature during which the solvent was removed and fresh solvent 
added three times. All extracts were combined and the extract was concentrated using a 
Büchi Rotavapor R-114 to yield 43.82 g of extract. This was applied to two TLC plates and 
developed in toluene: ethyl acetate (6:4). One plate was examined under UV and then 
developed using anisaldehyde : conc. H2SO4 : methanol [1:2:97] spray reagent while a 
bioautogram was produced for the other to identify antimicrobially active compounds. The 
extract (25 g) was then absorbed onto silica gel and dry packed onto a silica gel column (Φ 
4 cm). Polarity based fractionation was undertaken using the following systems: 
 
Fraction 1: hexane: dichloromethane (9:1) 
Fraction 2: hexane: dichloromethane (9:1) 
Fraction 3: dichloromethane: methanol (6:1) 
Fraction 4: dichloromethane: methanol (6:1) 
Fraction 5: methanol (100%) 
 
Bioactivity was confirmed in fraction 3 and 15.09 g was dry packed onto a second silica 
gel (Φ 5 cm) column. Toluene: ethyl acetate (6:4) was utilized to subfractionate the extract 
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to produce 153 subfractions. Fractions 51-60 (0.638 g) indicated bioactivity and the sample 
was again dry packed onto a column (Φ 1 cm). The mobile phase used was a hexane: ethyl 
acetate step gradient. The fractions (5 ml each) eluted are according to the following 
solvent system: 
 
Fractions 1-12: 5% ethyl acetate in hexane 
Fractions 13-54: 10% ethyl acetate in hexane 
Fractions 54-72: 15% ethyl acetate in hexane 
Fractions 73-92: 20% ethyl acetate in hexane 
Fractions 93-125: 30% ethyl acetate in hexane 
Fractions 126-136: 50% ethyl acetate in hexane 
Fraction 137: 100% ethyl acetate 
Fraction 138: 100% methanol 
  
Compound 1 was eluted in fractions 32-37, compound 2 was recrystalized from fractions 
42-45, compound 3 was recrystalized from fractions 78-84 and compound 4 was eluted 
from fractions 108-125. Compounds 1 and 4 were purified using a dichloromethane: 
methanol step gradient system utilizing a Pasteur pipette column. Compounds 2 and 3 were 
washed with hexane to remove any remaining impurities (Fig. 4.1). Compound 4 was 
isolated in insufficient quantities to provide adequate data for identification. 
                                                           
  
59 
                                                         Crude Extract 
                                                                   25g 
 
                                                                         Silica column (Φ 4 cm) 
                                                                                       Hexane: Dichloromethane (9:1) 
                                                                                       Dichloromethane: Methanol (6:1) 
                                                                                       Methanol (100%) 
 
5 fractions  
 
                                             Bioautographic  assay 
 
 
 Fraction 1               Fraction 2            Fraction 3               Fraction 4             Fraction 5 
   Inactive                   Inactive                  Active                       Inactive                Inactive 
 
                                                                        Silica column (Φ 5 cm) 
                                                                                       Toluene: ethyl acetate (6:4) 
 
                                                           153 Fractions 
 
 
 
 
                                                           Fractions 51-60 
                                                                Active 
 
                                                                        Silica column (Φ 1 cm) 
                                                                                       Hexane: ethyl acetate  
                                                                                       gradient 
 
138 Fractions 
 
Fractions 32-37           Fractions 42-45                Fraction 78-84          Fractions 108-125      
                Silica column                                                                                                         Silica column  
                   Dichloromethane:               Recrystalization                     Recrystalization           Dichloromethane: 
                   methanol                             Hexane                                   Hexane                         methanol                        
                   gradient                                                                                                                   gradient 
    
    Compound 1                       Compound 2                           Compound 3     Compound 4 [not  identified] 
    Fraction 38-50                  Yellow crystals                  Dirty white crystals        Fraction 111-130 
 
Fig. 4.1: Schematic representation of the purification steps for compounds isolated from H. 
saccifera. 
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4.2.3. Extraction and isolation of compounds from H. cuneifolia and H. salviifolia 
4.2.3.1. H. cuneifolia 
The powdered plant material (500 g) was extracted using acetone (1.5 L) over a period of 
48 hours at room temperature during which the solvent was removed and fresh solvent 
added three times. All extracts were combined and the extract was concentrated using a 
Büchi Rotavapor R-114 to yield 20.30 g of extract. The extract was then absorbed onto 
silica gel and dry packed onto a silica gel column (Φ 4 cm). Polarity based fractionation 
was undertaken using the following systems: 
 
Fraction 1: hexane: dichloromethane (9:1) 
Fraction 2: hexane: dichloromethane (9:1) 
Fraction 3: dichloromethane: methanol (6:1) 
Fraction 4: Methanol (100%) 
Fraction 5: Methanol (100%) 
 
In an effort to isolate compounds found in the very polar methanol fraction (F5), the 
fraction (3.9 g) was rechromatographed on a silica gel column using a step gradient solvent 
system of dichloromethane: methanol. Fractions of 50 ml each were collected from the 
column to produce 469 subfractions. Each subfraction was then concentrated by 
evaporating off the solvent. Compound 5 was eluted from subfractions 5-6. 
 
4.2.3.2. H. salviifolia 
The powdered plant material (500 g) was extracted using 1.5 L of acetone over a period of 
48 hours at room temperature during which the solvent was removed and fresh solvent 
added three times. All extracts were combined and the extract was concentrated using a 
Büchi Rotavapor.  The non-polar compounds were partitioned into dichloromethane and 
the liquid extract was decanted to produce 7.91 g of dichloromethane extract. This was 
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then chromatographed on a silica gel column using the step gradient system of 
dichloromethane: ethyl acetate, again 50 ml fractions were collected to produce 333 
fractions. Fraction 21 was rechromatographed on silica gel once again using the gradient 
system of dichloromethane: ethyl acetate. Subfractions of 1 ml were collected to produce 
55 fractions. Compound 6 was eluted from fraction 50-55. 
 
4.3. RESULTS AND DISCUSSION: 
4.3.1. Identification of Compound 1, E-17, 19-diacetoxy – 15 – hydroxylabda - 7,13 - 
diene 
 
 
 
 
 
 
[1] 
 
The LRMS of compound 1 indicated a molar mass of 406 g mol-1, which, in conjunction 
with the 1H and 13C NMR spectra (Appendix III), indicated a molecular formula of 
C24H38O5. The molecule was found to be a labdane diterpenoid with three of the methyl 
groups being oxidized to primary alcohols, two of which had been further acetylated. The 
two acetate groups were indicated by two acetate methyl group proton resonances at δ 2.06 
and δ 2.05 in the 1H NMR spectrum. The remaining methyl groups occurred at δ 1.65, 
δ0.89 and δ 0.77. The 13C NMR spectrum indicated the presence of two acetate carbonyl 
carbon resonances at δ 171.3, δ 170.9, two tri-substituted double bonds, and three 
oxymethylene carbons (δ 59.4, δ 67.5 and δ 72.7). The first double bond was placed in the 
13, 14-position with C-13 (δ 139.9) showing correlations in the HMBC spectrum 
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(Appendix III) with the 2H-15 resonances which occurred as a broad doublet at δ 4.13. 
This resonance showed coupling in the COSY spectrum (Appendix III)with the H-14 
resonance at δ 5.38 and the vinyl methyl group proton resonance at δ 1.65 which was 
assigned to 3H-16. 
 
The two methine carbon resonances at δ 44.0 and δ 51.7 were assigned to C-5 and C-9 
respectively. The HMBC spectrum showed correlations between the C-5 resonance and the 
3H-20 (δ 0.77) methyl group proton resonance, as well as the methyl group proton 
resonance at C-4 (δ 0.89). Further correlations were seen between C-5 and the pair of 
oxymethylene protons at δ 3.67 and δ 3.76. This indicated that one of the methyl groups at 
C-4 had been oxidized.  The C-9 resonance showed correlations in the HMBC spectrum 
with the 3H-20 methyl group proton resonance (δ 0.77) and the third oxymethylene proton 
resonance which occurred as a pair of doublets at  δ 4.42 and δ 4.56. These were assigned 
to the 2H-17 oxymethylene protons at C-8. The C-5 resonance showed coupling in the 
COSY spectrum with the 2H-6 resonance at δ 1.96, which was, in turn, seen to be coupled 
to the H-7 resonance at δ 5.75. Thus the second double bond was placed at C-7, and the 
fully substituted resonance at δ 133.9 was assigned to C-8. The HMBC spectrum indicated 
correlations between the acetate carbonyl resonances and the 2H-17 resonance and the 
oxymethylene group attached at C-4. Hence acetate groups were placed at these positions 
and a primary hydroxyl group was present at C-15. 
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Fig. 4.2: HMBC correlations for Compound 1 
 
A correlation in the NOESY spectrum (Appendix III) between the 2H-15 proton resonance 
and the 3H-16 resonance indicated they were cis to each other. A correlation between the 
3H-20 methyl group proton resonance and the methyl group at C-4, indicated, the methyl 
group at C-4 was in the β-configuration, and hence the acetylated oxymethylene group was 
α. The optical rotation of [α]D = + 5.2632 (chloroform) indicated that the compound 
belonged to the normal labdane series. (Zdero et al., 1991). Thus the structure was 
determined to be E-17, 19-diacetoxy – 15 – hydroxylabda - 7,13 - diene. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.3: NOESY correlations for Compound 1 
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This compound is a novel compound which has not been previously isolated. The novel 
nature of the compound suggests that the compound should be investigated for numerous 
bioactivities to determine its potential use in the treatment of disease. In addition since it 
has been isolated from H. saccifera, it would be interesting to note its contribution to the 
healing ability of the plant when utilized in traditional medicine. Due to the limited 
quantity of material available for investigation only the antimicrobial activity of the 
compound was explored as described in Chapter 5. 
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Table 4.1: 1H, 13C, COSY, NOESY, HMBC correlations for Compound 1 (CDCl3). 
 
Carbon 1H 13C HMBC COSY NOESY 
1 1.82, 1.86 38.3    
2 0.86, 1.51 17.8    
3 1.38 35.9    
4 - 36.5/36.3   3H-20 
5 1.46 dd 44.0 3H-20 2H-6  
6 1.96 m 2H 23.8  H-7  
7 5.75 bs 128.2    
8 - 133.9    
9 1.82 m 51.7 3H-20, 2H-17   
10 - 36.5    
11 1.57, 1.30 24.9    
12 2.10, 1.95 41.2    
13 - 139.9 2H-15 H-14, 3H-16  
14 5.38 bt 123.6    
15 4.13 bd 59.4   3H-16 
16 1.65 s 16.3   2H-15 
17 4.42 d 12.6 
4.56 d 12.6 
67.5    
18 0.89 s 17.6    
19 3.67 d 10.9 
3.76 d 10.9 
72.7    
20 0.77 s 14.0    
Acetatate C=O - 171.3, 
170.9 
   
Acetate CH3 2.06, 2.05 21.2, 
21.1 
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4.3.2. Identification of Compound 2, 5,8- dihydroxy-6,7,4’- trimethoxyflavone 
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[2] 
The mass spectrum of compound 2 showed a M+ peak at m/z 344. This was consistent with 
the molecular formula of C18H16O7. 
  
The 1H NMR spectrum (Appendix IV) showed a pair of doublets at δ 7.83 (J = 8.7) and δ 
6.96 (J = 8.7). These were attributed to the para-disubstituted proton of ring-B, H-2’/6’ 
and H-3’/5’ respectively.  
 
The 1H NMR spectrum also showed a single proton resonance at δ 6.57 which was 
attributed to H-3. Three methoxy group singlet resonances were seen at δ 4.09, δ 3.95 and 
δ 3.93. These resonances were typical of those of a flavone-type structure (Fig. 4.4). 
O
  O
 
Fig. 4.4: Typical flavone-type structure. 
 
The 13C NMR spectrum (Appendix IV) showed the presence of eighteen carbon resonances 
which were resolved using the HSQC spectrum into three methyl and five methine carbon 
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resonances. The 13C NMR spectrum also showed the presence of a carbonyl carbon 
resonance at δ 183.1. 
 
The COSY spectrum (Appendix IV) showed the typical coupling between the para-
disubstituted protons of H-2’/6’ and H-3’/5’. The NOESY spectrum (Appendix IV) 
showed a spatial correlation between H-2’/6’ and the resonance at δ 6.57 which indicated 
that this resonance was H-3. Another correlation was seen between H-2’/6’ and the 
methoxy group at δ 3.95 and therefore the methoxy group was assigned to H-4’. In 
addition, a NOESY correlation was seen between the methoxy groups at δ 4.09 and δ 3.93 
which implied that these were adjacent methoxy groups. 
 
The positions of the methoxy groups were confirmed by reference to literature which 
indicated that for hydroxyflavones whose NMR spectra are in CDCl3, the methoxy group 
signals at the 7-position were exhibited at a fairly low field shift in the range of 4.12 – 4.16 
(Horie et al., 1995). Thus the methoxy group at δ 4.09 was assigned as C-7. Further, Horie 
et al. (1995) indicated that although the difference between the 6- and 7- methoxy group 
signals were similar to that between 7- and 8- methoxy, the 6-methoxy group is more 
affected that the 8-methoxy group by the solvent such that the difference between the 6- 
and 7- methoxy signals (∆δ 0.11 – 0.16) are larger than that between 7- and 8- methoxy 
(∆δ 0.02 – 0.06). In this case, the difference was ∆δ 0.16, thus confirming that the second 
methoxy group most likely occurred at C-6 rather than C-8. Biosynthetically, these 
compounds always have an oxygenated substituent at C-5 and C-7 and hence a hydroxyl 
group was placed at C-5. This was confirmed by the 1H NMR spectrum which showed a 
broad singlet resonance at δ 12.52 which indicated the presence of a hydroxyl group at C-
5.  
 
  
68 
The HMBC spectrum (Appendix IV) showed a 3J correlation between the carbonyl carbon 
resonance and H-3, as expected. The methoxy group resonance at δ 3.95 was assigned to 
C-4’ because of HMBC correlations between the carbon resonance C-4’ (δ 159.3) and the 
methoxy group protons as well as to H-2’/6’ and H-3’/5’. A hydroxy group was assigned to 
C-8 to complete the fully-substituted ring-A. All other assignments of the quaternary 
carbons such as C-2, C-10 and C-1’ were confirmed by HMBC correlations and are listed 
in Table 4.2 and are indicated in Fig 4.5. below. 
O
OOH
OH
 OM e
  6'
  5'
 4'
3'
2'
 1'
 10
  9
  5  4
  3
  2
 1
MeO 
 
 
6
7  A
M eO  
 H
B
8
 
Fig. 4.5: HMBC correlations for Compound 2. 
 
A literature search revealed that compound 2 was 5,8- dihydroxy-6,7,4’- 
trimethoxyflavone (Horie et al., 1995). The correlations are listed in Table 4.2 and serve to 
confirm the structure.   
 
5,8-Dihydroxy-6,7,4’-trimethoxyflavone has previously been isolated from the genus 
Ocimum (Grayer et al., 2001) as well as Nepeta (Lamiaceae) (Jamzad et al., 2003). This 
compound has the unusual 5,8-dihydroxy-6,7-dimethoxy A-ring substitution pattern that 
may provide valuable and characteristic chemotaxonomic information.  It is an aglycone 
‘external flavonoid’ that is lipophilic in nature. They are amongst the rarely occurring 
flavonoids but this may be due to their disintegration which occurs during the process of 
isolation (Jamzad et al., 2003). The external flavonoids are especially common in species 
which grow in the wild arid and semi-arid regions, and are presumably present to provide 
the plant protection against harmful UV radiation (Grayer et al., 1996). These chemically 
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unstable surface flavones with an 8-hydroxylated group may be stored in some plants as 
the more stable 8-O-glycosides. The immediate precursor of 5,8-dihydroxy-6,7,4’-
trimethoxyflavone is probably the 8-deoxy derivative salvigenin (5-hydroxy-6,7,4’-
trimethoxyflavone) (Grayer et al., 2001) (Fig. 4.6) 
O
MeO 
MeO 
 OMe
OOH
H
 
Fig. 4.6: Structure of Salvigenin, probable precursor of 5,8-dihydroxy-6,7,4’-
trimethoxyflavone. 
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Table 4.2: 1H, 13C, COSY, NOESY, HMBC correlations for Compound 2 (CDCl3) as well 
as literature values in CDCl3 (Horie et al., 1995) 
 1H 1H Lit 13C HMBC COSY NOESY 
1       
2   162.1 H-3, H-2’/6’   
3 6.57s 6.58s 103.7   H-2’/6’ 
4   183.1 H-3   
5   145.7    
6   137.0 6-OMe   
7   153.0 7-OMe   
8   130.0    
9   149.5    
10   106.9 H-3   
1’   123.5 H-3, H-3’/5’   
2’6’ 7.83d 7.91d 128.4  H-3’/5’ H-3,H-4’,H-3’/5’ 
3’5’ 6.97d 7.02d 116.2  H-2’/6’ H-2’/6’ 
4’   159.3 H-3’/5’, H-2’/6’  H-2’/6’ 
5-OH 12.4s 12.34s     
8-OH       
6-OMe 3.93s 3.98s 61.15   H-7-OMe 
7-OMe 4.09s 4.14s 61.7   H-6-OMe 
4’-OMe 3.95s 3.89s 62.2    
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4.3.3. Identification of Compound 3, cirsimaritin 
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[3] 
 
The mass spectrum of compound 3 showed a M+ peak at m/z 314. This was consistent with 
the molecular formula of C17H14O6. 
  
The 1H NMR spectrum (Appendix V) showed a pair of doublets at δ 7.89 (J = 8.9) and δ 
6.93 (J=8.9). These were attributed to the para-disubstituted protons of ring-B, H-2’/6’ and 
H-3’/5’ respectively. The 1H NMR spectrum, in addition showed single proton resonances 
at δ 6.81 and δ 6.65 which were attributed to H-8 and H-3 respectively. These were typical 
of the splitting pattern for a flavone-type structure. Two proton methoxy group singlet 
resonances were seen at δ 3.97 and δ 3.82. 
 
The 13C NMR spectrum (Appendix V) indicated the presence of seventeen carbon 
resonances which were resolved using the HSQC (Appendix V) into two methyl and six 
methine carbon resonances. The HSQC spectrum correlated the proton resonances to their 
corresponding carbons. The 13C NMR spectrum also showed the presence of a carbonyl 
carbon resonance at δ 184.2.  
 
The COSY spectrum (Appendix V) showed typical coupling between the para-
disubstituted protons of H-2’/6’ and H-3’/5’. The NOESY spectrum (Appendix V) showed 
a spatial correlation between H-2’/6’ and the resonance at δ 6.65, therefore this resonance 
was attributed to H-3. Another correlation was seen between the single proton resonance 
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on the A-ring and one of the methoxy groups. This proton was assigned as H-8 by the 
HMBC (Appendix V) correlation seen between C-9, C10 and C-7 to this proton at δ 6.81. 
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Fig. 4.7: NOESY correlations for Compound 3. 
 
The positions of the methoxy groups at C-6 and C-7 were also confirmed using the HMBC 
spectrum. The C-6 carbon resonance ( δC 132.4) showed a HMBC correlation to the 
methoxy group attached at this position as well as a 4J correlation to H-8. The C-7 carbon 
resonance at δ 160.6 showed a HMBC correlation to its corresponding methoxy group 
substituent as well as to H-8. If a methoxy group was placed at C-5, there would be no 
correlation to the A-ring proton.  Biosynthetically, these compounds always have an 
oxygenated substituent at C-5 and C-7 and hence a hydroxyl group was placed at C-5. The 
presence of the hydroxyl at C-5 could not be confirmed on the 1H NMR spectrum as the 
deuterated methanol was used as a solvent.  
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Fig. 4.8: HMBC correlations for Compound 3. 
 
A literature search revealed that Compound 3 was 5,4’-dihydroxy-6,7-dimethoxyflavone 
(Hase et al., 1995) also known as cirsimaritin. All correlations are listed in Table 4.3 and 
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serve to confirm the structure. Differences in data from that of the literature are due to 
different solvents being utilized when NMR spectroscopy was conducted. 
 
Cirsimaritin is also one of the so called ‘external flavonoids’ or ‘surface flavonoids’. These 
compounds are aglycones and are, therefore, lipophilic constituents. They are not as 
universal in occurrence in higher plants as the more polar flavonoid glycosides, which 
occur in the vacuoles in the plant cells. They are therefore useful as taxonomic characters 
at various levels of classification (Jamzad et al., 2003). Further, cirsimaritin has also been 
indicated as being one of the main effective antioxidant phenolic compounds (Santos-
Gnomes et al., 2002), which will be considered in Chapter 6. Additionally, these lipophilic 
flavonoids may protect plants against infection by microorganisms, as several have been 
shown to have antibacterial or antifungal activities (Grayer et al., 1996).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
74 
Table 4.3: 1H, 13C, COSY, NOESY, HMBC correlations for Compound 3 (CD3OD) as 
well as literature values in CDCl3 (Hasrat et al., 1997). 
 1H 1H Lit 13C 13C Lit HMBC COSY NOESY 
1        
2   166.7 164.0 H-3, H-2’/6’   
3 6.65s 6.85s 103.8 102.6   H-2’/6’ 
4   184.0 182.1 H-3   
5   169.3 152.6    
6   132.4 131.9 6-OMe,H-8   
7   160.6 158.6 7-OMe, H-8   
8 6.82s 6.93s 92.3 91.5   7-OMe 
9   152.4 152.0 H-8   
10   105.1 105.1 H3, H8   
1’   123.1 121.0 H-3   
2’6’ 7.89d 7.96d 129.6 128.4  H-3’/5’ H-3, H-3’/5’ 
3’5’ 6.93d 6.94d 117.1 115.9  H-2’/6’ H-2’/6’ 
4’   162.9 161.3 H-2’/6’   
6-OMe 3.82s 3.74s 61.1 60.0    
7-OMe 3.97s 3.93s 57.0 56.4   H-8 
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4.3.4. Identification of Compound 5, lupeol 
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  [5] 
The 1H NMR spectrum (Appendix VI) suggested that a lupane structure was present. Two 
broad singlets at δ 4.55 and δ 4.67 (2H, brs, 2 x H-29) were due to the non-equivalent 
methylene protons at C-29. This was confirmed by the 13C NMR spectrum (Appendix VI) 
which showed signals at δ 109.3 and δ 150.9 due to the C-29 and C-20 carbons of the 
double bond. A downfield shifted methyl proton resonance at δ 1.66 in the proton spectrum 
indicated a vinyl methyl group in the proton spectrum and this resonance was assigned to 
3H-30. Six tertiary methyl group proton resonances occurred at δ 0.74, 0.77, 0.81, 0.92, 
0.95 and 1.01 and were due to H-24, H-28, H-27, H-23 and H-26 respectively. 
  
Also present in the proton spectrum was a broad doublet at δ 3.16 ascribed to H-3 and 
indicating the presence of a β-hydroxyl group at C-3. Deshielding caused by the oxygen 
atom of the hydroxyl group at C-3 shifted the methane signal downfield to δ 79.02 in the 
carbon spectrum.  
 
The 13C NMR spectrum showed the presence of 30 carbon atoms, which supported the 
proposed structure. The methine group at δ 55.3 was ascribed to C-5 and the fully 
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substituted carbon at δ 38.8 was ascribed to C-4 and are characteristic of a triterpenoid 
with the two methyl groups attached at C-4. 
 
The compound 5 isolated was thus found to be 3β-hydroxylup-20(29)-ene, which is 
commonly known as lupeol. This is a triterpenoid which is common in nature and has 
previously been isolated from many plant species including Asteraceae (Akihisa et al. 
1996), Euclea divinorum (Mebe et al., 1998), Crataeva nurvala (Geetha et al. 1998) as 
well as  Pimenta racemosa var. ozua (Fernándes et al., 2001). Thus, the data for lupeol was 
assigned by comparison with literature data (Aratanechemuge et al., 2004). It has been 
shown to possess anti-inflammatory (Geetha and Varalakshmi, 2001) as well as 
antimicrobial and cytotoxic activity (Ajaiyeoba et al., 2003). Thus, this compound was 
evaluated for activity against the 5-lipoxygenase enzyme (Chapter 7) as well as antioxidant 
activity (Chapter 6) 
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Table 4.4: 1H, 13C NMR spectral data for Compound 5 (CDCl3) as well the literature 
values in CD3OD (Aratanechemuge et al., 2004). 
Carbon Number 1H 1H Lit in CD3OD 13C 13C Lit in 
CD3OD 
1  1.65 38.7 38.7 
2  1.59 27.4 27.4 
3 3.16 dd 3.20 dd 79.0 79.0 
4   38.8 38.8 
5  0.68 55.3 55.3 
6  1.40 18.3 18.3 
7  1.32 34.2 34.3 
8   40.8 40.8 
9  1.29 50.4 50.4 
10   37.1 37.1 
11  1.20 20.9 20.9 
12  1.07 25.1 25.1 
13  1.68 38.0 38.1 
14   42.8 42.8 
15  1.00 29.7 27.4 
16  1.37 35.5 35.6 
17   43.0 42.9 
18  1.37 48.3 48.3 
19  2.38 47.9 47.9 
20   150.9 150.9 
21  1.37 29.8 29.8 
22  1.37 40.0 39.9 
23 0.95 s 0.97 s 28.0 27.9 
24 0.74 s 0.76 s 15.3 15.4 
25 0.81 s 0.83 16.1 16.1 
26 1.01 s 1.03 15.9 15.9 
27 0.92 s 0.94 14.5 14.5 
28 0.77 s 0.79 18.0 17.9 
29 4.55 brs, 4.67 brs 4.54 brs, 4.67 brs 109.3 109.3 
30 1.66 s 1.68s 19.3 19.3 
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4.3.5. Identification of Compound 6, β-sitosterol 
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[6] 
 
Comparison of the 1H NMR spectrum (Appendix VII) of Compound 6 with that of library 
spectra suggested that this compound was β-sitosterol. The 13C NMR spectrum (Appendix 
VII) showed an oxymethine carbon resonance occurring at δ 71.8 and this was typical for a 
carbon atom attached to an oxygen. This was therefore assigned to C-3. The fully 
substituted carbon resonance at δ 141.0 indicated the presence of one trisubstituted double 
bond and these resonances were assigned to C-5 and C-6 respectively. 
 
A multiplet at δ 5.32 in the 1H NMR was assigned to the H-6 proton. Another multiplet at δ 
3.50 could be ascribed to H-3α, with a hydroxyl group attached at C-3β. Chemical shifts 
for the methyl group protons correlated with the literature values and were assigned as 
follow: δ 0.66 (3H, s, H-18), δ 0.78 (3H, d, J=7.2, H-29), δ 0.91 (3H, d, J=6.4, H-21), δ 
0.99 (3H, s, H-19). 
 
This compound is a common triterpenoid and is quite widely distributed within the plant 
kingdom. 
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4.4. CONCLUSION: 
Three compounds have been isolated from the previously undescribed species, Hermannia 
saccifera. These have been identified as two flavones, 5,8- dihydroxy-6,7,4’- 
trimethoxyflavone and cirsimaritin, as well as one diterpene, E-17, 19-diacetoxy - 15 - 
hydroxylabda - 7,13 - diene. The presence of leaf surface flavonoids may prove useful as 
chemotaxonomic indicators for the genus. In addition, two known compounds, lupeol and 
β-sitosterol have been isolated from H. cuneifolia and H. salviifolia respectively. Although 
these compounds are fairly prominent throughout the plant kingdom, this is the first 
isolation of them from Hermannia species. All isolated compounds may possess biological 
activity and thus, may be contributors to the healing ability of Hermannia species and 
hence, their individual activities in certain assays were determined as detailed in 
forthcoming chapters.  
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CHAPTER 5: ANTIMICROBIAL ACTIVITY 
 
5.1. INTRODUCTION: 
A healthy person lives in harmony with the microbial flora that help protect them from 
invasion by pathogens (Beers and Berkow, 1999). An infection is a disease caused by a 
pathogen. It is the presence of a replicating organism, associated with tissue damage that 
defines a condition as an infection (Bannister et al., 2000). 
When penicillin became widely available during the Second World War, it was a medical 
miracle, rapidly vanquishing the biggest wartime killer - infected wounds. Discovered 
initially by a French medical student, Ernest Duchesne, in 1896, and then rediscovered by 
Scottish physician Alexander Fleming in 1928, the product of the soil mold Penicillium 
crippled many types of disease-causing bacteria. But just four years after drug companies 
began mass-producing penicillin in 1943, resistant microbes began to appear (Lewis, 
1995). 
The development of resistance in pathogenic bacteria is the greatest threat to the use of 
antimicrobial agents for therapy of bacterial infections. Since the introduction of penicillin, 
the discovery of each new antimicrobial compound has been followed by emergence of 
antimicrobial resistance (Aarestrup, 1999). Microorganisms can adapt to environmental 
pressures in a variety of effective ways, and their response to antibiotic pressure is no 
exception, with resistance occurring via the following mechanisms (Cloete, 2003): 
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• limited diffusion of antimicrobial agents through the biofilm matrix, 
• interaction of antimicrobial agents with the biofilm matrix ( cells and polymer), 
• enzyme mediated resistance, 
• level of metabolic activity within the biofilm, 
• genetic adaptation, 
• efflux pumps and, 
• outer membrane structure.  
An inevitable consequence of antimicrobial usage is the selection of resistant 
microorganisms. Overuse and inappropriate use of antibiotics has fueled a major increase 
in prevalence of multi-drug resistant pathogens, leading some to speculate that we are 
nearing the end of the antibiotic era. Unfortunately, as the need has grown in recent years, 
development of novel drugs has slowed. Thus, pending identification of new compounds, it 
seems that over the next decade we will have to rely on currently available families of 
drugs (Katzung, 2001). 
The ability of plants to produce diverse chemical compounds that are frequently used for 
the defense of the plant suggests that new, innovative compounds that possess 
antimicrobial activity may be found in these plants. Many traditionally used plants are 
utilized for diseases associated with infection and, thus, it is not unreasonable to assume 
that some of these plants may contain novel compounds that are so desperately needed to 
ensure that medicines will be available for future generations, when resistance to the 
currently available antibiotics has overruled any use of those life-saving drugs. 
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5.2. METHOD: 
Two methods were utilized in the determination of antibacterial activity for the twelve 
species of Hermannia i.e. minimum inhibitory concentration as well as the death kinetics 
assay. Isolation of active compounds was directed by a bioautographic assay. Acetone 
extracts were used for all assays.  
5.2.1. Minimum inhibitory concentration assay 
5.2.1.1. Principle of the method 
Minimum inhibitory concentrations (MICs) are defined as the lowest concentration of 
antimicrobial that will inhibit the visible growth of a microorganism after overnight 
incubation. They are considered the ‘gold standard’ for determining the susceptibility of 
organisms to antimicrobials (Andrews, 2001). The method investigates the ability of the 
microorganisms to produce visible growth in broth containing dilutions of the 
antimicrobial agent. The lowest concentration of an antimicrobial agent that, under in vitro 
conditions, prevents the appearance of visible growth of a microorganism within a defined 
period of time is recorded as the MIC (EUCAST, 2003). Tetrazolium salts are used to 
indicate biological activity because the colorless compounds acts as an electron acceptor 
and is reduced to a colored product (maroon) by biologically active organisms (Eloff, 
1998).  
5.2.1.2. Protocol 
A 96 well, sterile microculture plate was used to quantitate the antimicrobial activity as 
described by Eloff (1998) (Fig 5.1). The test solution (100 µl) was serially diluted 50 % 
with water and 100 µl of a three hour culture grown at 37°C in Mueller-Hinton broth was 
added to each well. The covered microplates were then, incubated overnight at 37°C. Eight 
cultures were used to ascertain the range of activity exhibited by Hermannia species: 
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• Staphylococcus aureus (ATCC 12600) (Gram-positive) 
• Staphylococcus epidermidis (ATCC 2223) (Gram-positive) 
• Enterococcus faecalis (ATCC 29212) (Gram-positive) 
• Bacillus cereus (ATCC 11778) ( Gram-positive) 
• Klebsiella pneumoniae (NTCC 9633) (Gram-negative) 
• Pseudomonas aeruginosa (ATCC 9027) (Gram-negative) 
• Candida albicans (ATCC 1023) (Yeast) 
• Cryptococcus neoformans (ATCC 901) (Yeast) 
To indicate bacterial growth, 40 µl of p-iodonitrotetrazolim violet (INT) dissolved in water 
was added to all microwells and then incubated at 37°C for 6 hours after which the lowest 
concentration at which inhibition of the micro-organism occurred was recorded. The assay 
was conducted with N ≥ 2. The control utilized was ciprofloxacin for the bacteria while 
Amphotericin B was used for the yeasts. Controls were used to determine the sensitivity of 
micro-organisms. 
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Fig. 5.1: Example of MIC plate. Maroon wells indicate growth of organism has occurred 
while the yellow wells indicate inhibition of microorganism growth. Concentrations 
decrease from 64 mg/ml to 0.125 mg/ml. 
5.2.2. Bioautographic assay 
5.2.2.1. Principle of the method 
Thin-layer chromatography is the simplest and cheapest method of detecting plant 
constituents. Bioautography is a very convenient way of testing plant extracts and pure 
substances for their effects against pathogens. It can be employed in target-directed 
isolation of active constituents. One of the bioautographic methods that have been 
described is agar diffusion in which the antimicrobial agent is transferred from the 
chromatogram to an inoculated agar plate through a diffusion process. It is applicable to a 
broad spectrum of microorganisms. It produces well defined zones of inhibition and is not 
sensitive to contamination. Active compounds are transferred by diffusion from the 
stationary phase to the agar layer which contains the microorganism. After incubation, the 
plate is sprayed with a tetrazolium salt which is converted to a formazan dye by the 
microorganism. Inhibition zones are observed as clear spots against a purple background 
(Marston and Hostettmann, 1999). 
Decreasing 
concentration 
MIC 
64 mg/ml 
0.125  mg/ml 
H. saccifera 
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5.2.2.2. Protocol 
A thin-layer chromatography (TLC) plate to which the extracts had been applied, was 
developed in the solvent system toluene: ethyl acetate (6:4). The plate was placed in ultra 
violet light for one hour to eliminate any contamination that may have been present. The 
plates were placed on a, previously poured, fifteen milliliter agar base in a Petri dish and 
covered with fifteen milliliters of agar, inoculated with 150 µl of Staphylococcus aureus 
(ATCC 12600). The plate was allowed to predefuse for one hour in the fridge and 
incubated at 37 °C overnight. 
After 24 hours, the bacteria-covered plate was sprayed, using an atomizer, with a 2 mg/ml 
p-iodonitrotetrazolium violet (INT) aqueous solution. The bacteria stained dark red by the 
INT such that zones of inhibition were clearly visible where bacterial growth has been 
inhibited. Zones on the TLC plate that remained clear indicated compounds that exhibit 
antibacterial activity (Marston and Hostettmann, 1999). 
5.2.3. Death kinetics assay 
5.2.3.1. Principle of assay 
Death kinetics or time-kill studies are commonly used to investigate new antimicrobial 
agents (Tam et al., 2005). Data collected from time-kill studies have provided critical 
information regarding the rate and extent of bactericidal activity. These data have 
significantly enhanced our understanding regarding the dynamic relationships which exist 
between antimicrobial agents and their effects on bacteria (Klepser et al., 1998). The 
diversity of various bacterial responses to antibiotics cannot easily be understood without 
establishment of a time-kill curve. A typical time-kill curve generated by subjecting the 
test organism to exposure at constant antibiotic concentrations normally consists of a lag 
phase, a log-linear killing phase, a second lag phase as well as a regrowth phase (Li, 2000). 
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The determination of death kinetics enables the differentiation between microbiostatic and 
microbiocidal effects (Christoph and Stahl-Biskup, 2001). Thus, time-kill curves are 
figurative representations of bacterial concentrations (CFU/ml) in subcultures taken 
serially from cultures, usually in liquid media, containing antibiotics from which killing 
kinetics can be derived (European Society of Clinical Microbiology and Infectious 
Diseases, 2000) 
5.2.3.2. Protocol 
The inactivation broth death kinetic method described by Christoph and Stahl-Biskup, 
(2001) was used to determine the antimicrobial activity of H. saccifera which was chosen 
based on the promising results obtained in the MIC determination. Staphylococcus aureus 
(ATCC 12600) was cultured overnight at 37ºC on Tryptone Soya Agar (TSA). The 
colonies were then seeded into sterile 0.9 g/L NaCl solution. Serial dilutions (10-1 to 10-4) 
were carried out in 0.9 g/L NaCl which provided a final colony count in the lowest dilution 
of 173 colonies per plate. In addition, the optical density of the solution (absorbance) of 
bacteria was determined as 0.023. Suspensions (final volume of 50 ml) were made 
containing 0.1, 0.25, 0.5 and 0.75 % w/v of an acetone extract of H. saccifera which was 
first dissolved in 2.5 ml of acetone and thereafter added to Tryptone Soya Broth and was 
placed in a shaking water bath at 37ºC. A control was run in the same way without the 
addition of the extract. Aliquots of 1 ml were sampled after 0, 5, 15, 30, 60, 120 and 240 
min as well as at 8 and 24 hours and were transferred to 9 ml of inactivation broth 
containing 0.1 % peptone, 5 % lecithin and 5 % yeast extract and then vortex stirred. Four 
serial dilutions were performed in 0.9 g/L NaCl solution (1 in 10 dilutions) from the 
inactivation broth. Samples of each dilution (100 µl) as well as from the inactivation broth 
were plated on TSA.  The plates were then incubated for 24 hours at 37°C after which the 
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number of colonies were counted. The assay was performed in duplicate. Activity was 
determined by plotting log10 colony counts (CFU/ml) against time.   
5.3. RESULTS: 
5.3.1. Minimum inhibitory concentration 
Table 5.1 indicates the MIC results for all twelve species of Hermannia as well as the 
isolated compound [1]. All twelve species investigated indicated activity against all 
organisms tested. Most values ranged from 2-4 mg/ml with only H. flammula indicating 
limited activity against C. albicans and S. aureus with values of greater than 16 and 8 
mg/ml respectively. In addition, H. althaeifolia, H. holosericea and H. scabra produced 
values of 8 mg/ml against E. faecalis. 
The most activity, however, was obtained by H. saccifera which indicated 0.0195 mg/ml 
(19.5 µg/ml) as the MIC against both S. aureus and B. cereus and an MIC of 0.125 mg/ml 
against E. faecalis. H. salviifolia and H. scabra had MIC values of 0.5 mg/ml against P. 
aeruginosa, as did H. muricata, H. cuneifolia, H. saccifera and H. scabra against C. 
neoformans. 
The novel compound, E-17, 19-diacetoxy - 15 - hydroxylabda - 7,13 - diene, isolated from 
H. saccifera produced an MIC of  0.0263 mg/ml (26.3 µg/ml) against S. aureus, 0.0943 
mg/ml (94.3 µg/ml) against E. facials as well as 0.0472 mg/ml (47.2 µg/ml) against B. 
cereus. 
The results indicate that the species tested have similar antimicrobial activity against both 
Gram-negative and Gram-positive organisms as well as against the yeasts.  
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5.3.2. Bioautographic assays 
The bioautogram for H. saccifera on S. aureus (ATCC 12600) indicated that there are at 
least two to three compounds that are responsible for antimicrobial activity of the plant 
(Fig 5.2) and thus served as a focus for isolation. 
In addition, a bioautogram conducted on H. althaeifolia, showed that while the crude 
extract did not possess visible antimicrobial activity, the fraction obtained from the column 
chromatography did have activity (Fig 5.3). 
 
Fig. 5.2: Bioautogram of crude extract of H. saccifera on S. aureus (ATCC 12600) 
indicating two or three compounds that possess antimicrobial activity. 
 
 
COMPOUNDS 
POSSESSING 
ACTIVITY 
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Fig. 5.3: Bioautogram of H. althaeifolia on S. aureus (ATCC 12600) indicating lack of 
antimicrobial activity in the crude extract with activity being present in fraction 1-3. 
 
5.3.3. Death kinetics assay 
 
The time-kill plot of H. saccifera is displayed in Fig 5.4. The antibacterial activity of all 
concentrations was noticeable after 60 min of exposure time. The activity of this plant is 
concentration dependant with exposure to the plant extracts over time resulting in a reduction 
of colony forming units. All concentrations exhibited antibacterial activity over time with 
most concentrations achieving at least a 4-5 log10 reduction in bacterial count after 8 hours. 
Concentrations of 0.1, 0.25 and 0.5 % indicated bacteriostatic activity while the 0.75 % (7.5 
mg/ml) extract achieved complete bactericidal activity after 240 min.  Regrowth of 
microorganisms did not occur at any concentration being investigated within the 24 hour test 
period. 
Crude Extract Fraction 1-3 
F1 F2 F3 
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Fig. 5.4: Death kinetics of Staphylococcus aureus exposed to various concentrations of H. 
saccifera. 
 
5.4. DISCUSSION: 
The crude extracts of all twelve plants possessed inhibitory effects on the test organisms 
selected and this activity was shown to be a concentration dependant inhibition. Duarte et al. 
(2005) suggested that extracts presenting an MIC below 2.0 mg/ml should be considered as 
having potential antimicrobial activity. Further, Aligiannis et al. (2001) proposed a 
classification for plant materials based on MIC results as follows: strong inhibitors – MIC up 
to 0.5 mg/ml; moderate inhibitors – MIC between 0.6 and 1.5 mg/ml; weak inhibitors above 
1.6 mg/ml. Thus, while most extracts do possess potential antimicrobial activity, many exhibit 
weak activity. However, a few species as listed in Table 5.1 have indicated moderate activity. 
In addition, H. cuneifolia, H. involucrata, H. muricata, H. salviifolia and H. scabra have 
indicated strong activity against organisms, P. aeruginosa and C. neoformans.   
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It is interesting to note that the species had broad spectrum activity that was inhibitory to 
Gram-positive and Gram-negative bacteria as well as yeasts. Generally, previous research 
conducted on plant extracts has indicated that they are more active against Gram-positive 
rather than Gram-negative bacteria (Lin et al., 1999). Hermannia could be producing 
compounds with broad spectrum activity against a host of micro-organisms, making the plant 
very useful in the treatment of infections. In addition, antifungal agents are amongst the most 
expensive antibiotics. Thus, readily accessible and inexpensive alternative remedies for 
treatment of fungal infections, is required (Salie et al., 1996). The species were found to 
produce good antifungal activity against the two yeasts tested, and may, thus, be useful as an 
antifungal agent. 
 
The most promising results were obtained for H. saccifera against S. aureus (ATCC 12600) as 
well as B. cereus (ATCC 11778) with MICs of 19.5 µg/ml. It must be taken into consideration 
that these are MIC values for crude extracts and it is expected that the isolated active 
compound should have increased activity. This activity is promising as it is highly active 
against S. aureus which known to be resistant to many antimicrobial agents (Lechner et al., 
2004). In addition, the plant is highly active against B. cereus which is also a Gram-positive 
organism. Hermannia depressa which is the only species of Hermannia investigated for 
antimicrobial activity, to date, ranges from 0.195 to 3.125 mg/ml against S. aureus and B. 
cereus (Reid et al., 2005) indicating that H. saccifera has much greater activity than any other 
Hermannia species tested. Thus, the isolation of these compounds were imperative to identify 
the actual compounds responsible for this activity. The bioautogram (Fig 5.2) indicated that 
there were two to three compounds contributing to this activity. Isolation was attempted using 
bioassay-guided fractionation as discussed in Chapter 4. 
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The activity of H. saccifera with the MIC against S. aureus (ATCC 12600) being 19.5 µg/ml, 
prompted the testing of the plant extract in the death kinetics assay to determine the 
bactericidal activity over time. There was an initial decrease in viable cell counts for all 
concentrations including the control. After the first 30 min the viable colony count for the 
control increased. The lower concentrations of 0.1, 0.25 and 0.5 % showed bacteriostatic 
activity, as after an initial decrease in viable cell counts further growth was prevented but S. 
aureus was not killed off by the presence of the plant extract. The time-kill curve (Fig 5.4.) 
indicates that the activity of the plant extract against S. aureus is concentration dependant as 
well as that exposure to the plant extract over time results in a reduction in colony forming 
units.  
 
The plant as indicated previously portrayed very low MIC values (i.e. 19.5 µg/ml) against the 
same strain of S. aureus. These time-kill results do not correlate with these excellent MIC 
results. However, bactericidal or bacteriostatic activity cannot be predicted by MIC (Krueger 
et al., 2001) and thus, the plant may produce a low MIC value but this activity may be 
bacteriostatic with only high concentrations of extract i.e. 0.75% (7.5 mg/ml) producing 
bactericidal activity.  
 
The results did indicate that no regrowth of micro-organisms occurred during the time period 
being assessed. In addition, rapid killing of micro-organisms was not observed as a decrease in 
viable cell count compared to the control was only observed after 60 minutes. 
 
One of the compounds contributing to the antimicrobial activity of H. saccifera was isolated 
and identified as E-17, 19-diacetoxy - 15 - hydroxylabda - 7,13 - diene (Chapter 4). This 
compound produced interesting results when minimum inhibitory concentrations were 
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determined. The MIC against S. aureus was established to be 23.6 µg/ml. This was a 
promising result indicating that the compound does indeed contribute to the antimicrobial 
activity. However, this value was less than that produced by the plant extract itself which was 
19.5 µg/ml. This indicates, in addition to confirming the bioautogram results, that there are a 
number of compounds found within the plant that together produce the total antimicrobial 
activity. This is further displayed in the increased MIC of 47.2 µg/ml against B. cereus when 
the crude plant extract produced an MIC of 19.5 µg/ml. Only in the case of E. faecalis was the 
result produced for the compound (94.3 µg/ml) less than that of the extract (125 µg/ml) 
suggesting that this compound contributes significantly to the antimicrobial activity of the 
plant against this bacterial species. It is therefore evident that while this novel compound may 
not be used as an antibacterial agent in its present form, it does indicate promising activity 
against several bacteria and may, thus, prove to be an interesting lead compound in the 
development of new antimicrobial drugs. Hence further investigation into the chemical 
structural components of the compound is required to determine the structure-activity 
relationships and thereafter, chemical synthesis of related compounds with increased activity 
is necessary. 
 
One further interesting aspect was the results of the bio-autogram conducted on H. 
althaeifolia, in which the crude extract showed no antimicrobial activity yet after column 
fractionation activity was exhibited (Fig 5.3). This could be due to antagonism present in the 
crude extract which had been eliminated in the fraction. Conversely, the results may have been 
due to the assay not being sensitive enough to obtain activity in the crude extract in which the 
concentration of active compound would have been much less than that of the enriched 
fraction. This aspect warrants further investigation.  
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Staphylococcus aureus is an opportunistic organism which only becomes pathogenic when the 
immune system of a patient is compromised. They contribute significantly to the initiation of 
infection and are commonly associated with skin and wound infections (Bannister et al., 
2000). The results indicate that the selected species are effective against S. aureus especially 
H. saccifera and therefore, they can be utilized in the treatment in the above conditions. S. 
epidermidis is also associated with skin infections and again the plants activity against this 
microorganism with H. saccifera portraying the best activity with an MIC of 1 mg/ml. 
 
The plants all exhibited promising activity against P. aeruginosa (ATCC 9027) which is 
naturally resistant to many antimicrobial agents (Konning et al., 2004). Thus, the isolation of 
compounds from the most active extracts may produce compounds that are active against P. 
aeruginosa making it useful for these resistant organisms. This organism is associated with 
middle ear suppuration in children, destructive lesions of the skin, and infections of the genito-
urinary tract, respiratory tract, the joints and the eye. It is also associated with a dysentery-like 
enteric infection and in pneumonia (Bannister et al., 2000). E. faecalis is the cause of 
endocarditis, urinary tract infections, intra-abdominal infections cellulites and wound infection 
as well as concurrent bacteremia. Klebsiella pneumoniae is associated with pneumonia, 
bronchitis and other respiratory diseases (Beers and Berkow, 1999). Bacillus cereus has been 
implicated in gastrointestinal, wound, and ocular infections to name a few (Kotiranta et al., 
2000). Thus, the plant species active against these organisms has many important implications 
for the treatment of diseases associated with these organisms. 
 
Activity portrayed by the selected species against Candida albicans may provide interesting 
compounds especially if the isolated compounds have increased activity compared to the crude 
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extracts. Candida albicans is an opportunistic pathogen that commonly affects 
immunologically compromised patients (Duarte et al., 2005) and the plants may, thus, be 
useful in the treatment of opportunistic infections associated with HIV/AIDS.  Cryptococcus 
neoformans is associated with meningitis or as generalized infection (Bannister et al., 2000). 
The inhibition of this organism by the plant extracts suggests that the compounds producing 
this activity should be further investigated with regards to its ability to cross the blood brain 
barrier since this is a requirement for the treatment of meningitis during in vivo testing. 
 
Traditional usage of these plants includes skin and wound as well as respiratory infections, 
burns and dysuria, amongst a few. These conditions are caused or exacerbated through a 
number of micro-organisms including those used in the investigation above thus, providing a 
scientific basis for the traditional use of the plants. 
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5.5. CONCLUSION: 
All plants extracts from the selected Hermannia species exhibit antimicrobial activity with H. 
saccifera exhibiting the most potent activity with an MIC of 19.5 µg/ml against S. aureus and 
B. cereus. The death kinetics of H. saccifera indicates that the antibacterial activity is 
bacteriostatic rather than bactericidal with only very high concentrations of the extract 
producing bactericidal activity. Two to three compounds have been implicated as producing 
this activity in H. saccifera. A novel compound identified as E-17, 19-diacetoxy - 15 - 
hydroxylabda - 7,13 - diene produced good MIC results and may be an important lead 
compound in the development of new antimicrobial drugs. In addition, the activity displayed 
can be correlated to the traditional usage of the plants, thus providing a scientific basis for the 
use of these plants in traditional healing to treat infectious diseases. 
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CHAPTER 6: ANTIOXIDANT ACTIVITY 
 
6.1 INTRODUCTION: 
The role of free radical reactions in biology has become an area of intense interest. Free 
radicals play an important role in the development of tissue damage and pathological events in 
living organisms. In aerobic life, lipids containing polyunsaturated fatty acids, proteins, 
nucleic acids and carbohydrates can be oxidized by free radical-mediated reactions (Velázquez 
et al., 2003). 
Electrons in atoms occupy regions of space known as orbitals. Each orbital can hold a 
maximum of two electrons, spinning in opposite directions. A free radical can be defined as 
any species capable of independent existence that contains one or more unpaired electrons, an 
unpaired electron being one that is alone in an orbital. Since electrons are more stable when 
paired, radicals generally are more reactive (Halliwell, 1991). 
Aerobic life uses oxygen to oxidize carbon and hydrogen rich substrates to obtain chemical 
energy and heat essential for life. Unfortunately, when this occurs, the oxygen molecule itself 
becomes reduced and forms intermediates; two of which are free radicals (Eqns 1- 4). 
                            O2 + e + H+  HO2
.           Hydroperoxyl radical 
HO2
.    H+ +  O2
-             Superoxide radical                            (1) 
O2
- + 2H+ + e  H2O2       Hydrogen peroxide                           (2) 
H2O2 + e  OH
- + .OH      Hydroxyl radical                               (3) 
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.OH + e + H+  H2O                                                                   (4) 
Eqn 1 indicates the addition of an electron which causes oxygen to be reduced creating the 
free radical HO2.. At the physiological pH of 7.4, the hydroperoxyl radical dissociates to give 
the superoxide anion radical (O2-) (Gutteridge, 1994). Dismutation (Eqn 2), further, causes 
hydrogen peroxide to be formed. In the presence of trace metals, the superoxide anion and 
hydrogen peroxide undergo the so-called Haber-Weiss reaction which results in the hydroxyl 
radical (.OH) formation (Kappus, 1987). In addition, hydroxyl radicals may also originate 
from hydrogen peroxide in the presence of greater amounts of reduced metal ions by the 
Fenton reaction (Halliwell and Gutteridge, 1984). 
H2O2 + Fe2+ + H+  HO
. + Fe3+ + H20 
 
.OH is the most reactive radical known to chemistry. It can attack and damage almost every 
molecule found in living cells. Reaction of .OH with biological molecules set off chain 
reactions. The ability of .OH to stimulate the free radical chain reaction, known as lipid 
peroxidation, is perhaps, the best characterized biological damage caused by this molecule.  In 
the close vicinity of membranes, .OH attacks the fatty acid side chains of the membrane 
phospholipids, resulting, ultimately, in the production of lipid hydroperoxides. These disrupt 
membrane function through accumulation, causing it to collapse (Gutteridge, 1994). Both O2- 
and H2O2 are far less reactive than .OH but they are not completely harmless as both can 
produce direct injury to a few cellular sites if they are generated in excess but .OH remains the 
most deleterious in its effects.  
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Aerobic organisms are protected against oxygen toxicity by a natural antioxidant defense 
system involving enzymatic and non-enzymatic mechanisms (Velázquez et al., 2003). In 
healthy individuals, the production of free radicals is balanced by the antioxidative defense 
system. However, oxidative stress is generated when the balance is in favor of the free radicals 
as a result of an increased production or depletion of antioxidant levels (Parejo et al., 2002). 
The term ‘antioxidant’ is frequently used in biomedical literature, but rarely is it defined, with 
a strong implication that it refers to chemicals with chain breaking properties such as vitamin 
E and vitamin C. It may also be defined as “any substance that when present at low 
concentrations, compared to those of the oxidizable substrate, significantly delays, or inhibits, 
oxidation of that substrate” (Gutteridge, 1994). 
Antioxidants can act at several different stages in an oxidative sequence, such as: 
(1) removing oxygen or decreasing local O2 concentrations; 
(2) removing catalytic metal ions; 
(3) removing key reactive oxygen species 
(4) scavenging initiating radicals such as .OH, RO., RO2.; 
(5) breaking the chain of an initiated sequence;  
(6) quenching or scavenging singlet oxygen (Gutteridge, 1994). 
A wide range of methods are currently used to assess antioxidant capacity, for example for 
measurement of prevention of oxidative damage to biomolecules such as lipids or DNA and 
methods assessing radical scavenging. Both in vivo and in vitro assays are used and all 
methods have their own advantages and limitations (van den Berg et al., 1999). Radical 
scavenging assays relate to the generation of a different radical, acting through a variety of 
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mechanisms and the measurement of a range of end points at a fixed time point or over a 
range. Two types of approaches have been taken, namely, the inhibition assays in that the 
extent of the scavenging of hydrogen – or electron- donation of a pre-formed free radical is the 
marker of antioxidant activity, as well as assays involving the presence of an antioxidant 
system during the generation of the radical (Re et al., 1999) 
Traditional medicine all over the world is nowadays revalued by an extensive activity of 
research on different plant species and their therapeutic principles. Plants, generally, produce 
many antioxidants to control the oxidative stress caused by sunbeams and oxygen and it is 
thus possible that they can represent a source of new compounds with antioxidant activity 
(Scartezzini and Speroni, 2000) that may be useful in providing protection against various 
diseases such as cancers, cardio- and cerebrovascular disease which have been associated with 
free radical damage (du Toit et al., 2001). 
6.2. METHODS: 
 
Two assays were utilized to identify the antioxidative ability of the twelve species i.e. 2,2-
diphenyl-1-picrylhydrazyl (DPPH) assay as well as the 2,2′-azino-bis(3-ethyl-benzthiazoline-
6-sulfonic acid) (ABTS) assay. Solutions of 10 mg/ml in methanol were made for each sample 
from which further dilutions were made. Antioxidant activity of the isolated flavone 
compounds, 5,8- dihydroxy-6,7,4’- trimethoxyflavone and cirsimaritin, isolated in Chapter 4, 
were only investigated in the DPPH assay due to the limited amounts of pure compound 
available. 
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6.2.1. 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay 
 
6.2.1.2. Principle of  the method: 
 
The DPPH free radical scavenging assay is a simple and widely used screen for bioactive 
compound discovery. The molecule, DPPH is characterized as a stable free radical by virtue of 
the delocalization of a spare electron over the molecule as a whole. This delocalization gives 
rise to a deep violet color, characterized by an absorption band at 517 nm. 
 
When a solution of DPPH is mixed with that of a substance that can donate a hydrogen atom 
this gives rise to the reduced form with the loss of the violet color such that a pale yellow 
color forms due to the presence of the picryl group (Fig 6.1.). Antioxidant activity is evaluated 
by the decrease in absorption as a result of the conversion of the purple DPPH radical color to 
that of yellow when this reduction occurs.  
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.1: Reaction of DPPH radical with antioxidative substance (FlOH). 
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The reaction is intended to provide the link with the reactions taking place in an oxidizing 
system, such as the autoxidation of a lipid or other unsaturated substance i.e. the DPPH 
represents free radicals formed in the system whose activity is suppressed by a substance that 
has a hydrogen donating ability (Molyneux, 2004).  
 
6.2.1.3. Protocol 
6.2.1.3.1. Microtitre plate method 
This is a colorimetric method described by Shimada et al. (1992) which investigates the 
radical scavenging ability of a sample using the DPPH radical. Quantitative measurement of 
radical scavenging properties was carried out in a 96 well microtitre plate using analytical 
grade ascorbic acid as the reference compound (Fig 6.2). Each well contained 50 µl of sample 
solutions (100 µg/ml) as well as 200 µl of DPPH (0.077 mmol.L-1) (Fluka) dissolved in 
methanol (Ultrafine Ltd). Negative controls contained 50 µl of sample and 200 µl methanol 
without any DPPH. Measurements were performed in triplicate. The microtitre plate was 
placed on a Labsystems Multiskan RC microtitre plate reader and shaken for two minutes after 
which it was allowed to react for a further 30 minutes in the dark before a reading was taken at 
550 nm. Samples having activity of less than 100 µg/ml were then serially diluted and results 
obtained at varying concentrations. Enzfitter® version 1.05 software was used to calculate the 
IC50 values which denote the concentration of sample required to scavenge 50 % of the DPPH 
radical. 
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Fig. 6.2: Example of microtitre plate. The purple wells refer to the maximum reaction of 
DPPH while yellow wells indicate antioxidant activity. Clear wells are the control for each 
sample. Boxed area refers to the reaction of one sample at 100 µg/ml assayed in triplicate. 
 
6.2.1.3.1. Thin layer chromatographic analysis 
A chloroform: methanol (1:1) extract of the twelve selected species of Hermannia were 
diluted to a concentration of 50 mg/ml using methanol and 2 µl of this solution was applied to 
an aluminium backed silica plate (Macherey-Nagel) using a calibrated glass capillary tube 
(Hirschmann Laborgerate).  The TLC plate was developed in a mobile phase TLC 2 as 
described in Chapter 3.  Positive free radical scavenging / anti-oxidant activity was confirmed 
by spraying the plate with DPPH solution (0.04 % in HPLC grade methanol) using an 
atomizer.  Color development occurred immediately. Activity was indicated by active 
molecules appearing as yellow zones against a purple background.     
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6.2.2. 2,2′-azino-bis(3-ethyl-benzthiazoline-6-sulfonic acid) (ABTS) assay 
 
6.2.2.1. Principle of the method 
 
The ABTS antioxidant assay is based on the TEAC (Trolox Equivalent Antioxidant Capacity) 
assay originally described by Miller et al. (1993) which involves the scavenging of long-lived 
radical anions.  The TEAC assay was based on the reduction of the accumulation of ABTS. 
formed by the peroxidase activity of metmyoglobin by antioxidants. However, a major 
impediment to this assay is that compounds may inhibit peroxidase activity (Strube et. al., 
1997). Therefore, the assay has been adapted by using preformed ABTS. (van den Berg et al., 
1999).  
 
This method involves the direct production of the ABTS.+ chromophore through the reaction 
between ABTS and potassium persulphate (Fig 6.3). This has absorption maxima at 
wavelengths 645, 734, and 815 nm. The radical generated is capable of reacting with both 
water soluble and lipid soluble antioxidants as well as pure compounds and food extracts. 
Addition of antioxidants to the preformed radical cation reduces it to an extent depending on 
the antioxidant activity and the concentration of the antioxidant. This converts the blue/green 
color to colorless through scavenging of the stable ABTS.+  radical (Re et. al., 1999). The 
degree of discoloration reflects the amount of ABTS.+ that has been scavenged and can be 
determined spectrophotometrically (Arts et al., 2003). 
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Fig. 6.3: Reaction showing the production of ABTS.+. 
 
 
6.2.2.2. Protocol 
The radical scavenging activity of all extracts were determined using the 2,2 - azino-bis(3-
ethylbenz-thiozoline-6-sulfonic acid) (ABTS) assay described by Miller et al. (1993) and 
modified by van den Berg et al. (1999). A 7 mM ABTS (Sigma Aldrich) stock solution was 
prepared in double distilled water. The ABTS radical cation (ABTS.+) was produced by 
reacting 5 ml of ABTS solution with 88 µl of a 140 mM potassium persulphate (K2S2O8) 
(Fluka)  solution and the mixture was allowed to stand in the dark for 12-16 hours to stabilize. 
The radical solution is stable for two days in the dark.  
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Prior to the assay, the ABTS.+  solution was diluted in cold ethanol to give an absorbance of 
0.70 ± 0.02 at 734 nm in a 1 cm cuvette. Ethanol and methanol were used as negative controls. 
The radical scavenging activity was quantitated by reacting 1 ml of ABTS. + solution with 50 
µl of sample. Trolox (6-hydroxy-2,5,7,8-tetramethylchromon-2-carboxylic acid) (Sigma 
Aldrich) was used as a positive control. The mixture was heated for 4 min after which the 
absorbance was read at 734 nm on a Specord 40 spectrophotometer. Measurements were 
performed in triplicate. The percentage inhibition was then plotted as a function of the 
concentration, from which the equation of the straight line was calculated. The concentration 
that produced 50 % decolorisation (IC50) was determined as well as the standard deviation.   
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6.3. RESULTS: 
Table 6.1 and Fig 6.4 summarize the radical scavenging activity of the twelve selected species 
of Hermannia in the DPPH and ABTS antioxidant assays. Most species portrayed promising 
antioxidant activity in both assays with H. cuneifolia possessing the most significant activity 
with a concentration to produce 50 % decolorisation (IC50) of 10.26 ± 0.29 and 10.32 ± 0.34 
(µg/ml) in the DPPH and ABTS assays respectively. 
 
Ten of the twelve species possessed activity with IC50 ranging from 10-30 µg/ml with only 
one species, H. trifurca, indicating moderate activity and one species, H. salviifolia, showing 
limited activity in both assays. No extracts were found to exhibit a higher radical scavenging 
activity than the positive controls, ascorbic acid and Trolox which IC50 values of  2.46 ± 0.01 
and 2.96 ± 0.001 µg/ml respectively. 
 
Both isolated flavone compounds investigated, i.e. 5,8- dihydroxy-6,7,4’- trimethoxyflavone 
and cirsimaritin, exhibited poor activity with both compounds having an IC50 of greater than 
100 µg/ml thus, indicating almost no activity against the DPPH radical.  
 
In addition, the values obtained for each species in both assays indicates some correlation with 
the ABTS assay producing only slightly better activity in most species than the DPPH assay. 
 
The results obtained from the TLC analysis indicate that there are a number of compounds in 
each species that portray antioxidant activity (Fig 6.5). Many compounds that produce activity 
are found in all species being investigated as can be seen from similar Rf values being 
obtained for these compounds. In addition, only 5,8- dihydroxy-6,7,4’- trimethoxyflavone 
indicates slight activity while cirsimaritin is not active against the DPPH free radical (Fig 6.6). 
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Fig. 6.4: Bar graph comparing results obtained for DPPH and ABTS assays indicating 
similarities between the results and the consistent lower results of the ABTS results. 
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Table 6.1: DPPH and ABTS antioxidant activity of selected species of Hermannia. 
DPPH ASSAY ABTS ASSAY  
Species/Compounds IC50 (µg/ml) Std dev IC50 (µg/ml) Std dev 
H. althaeifolia 14.73 0.79 11.86 0.64 
H. cuneifolia 10.26 0.29 10.32 0.34 
H. flammula 18.91 1.13 19.56 0.24 
H. holosericea 14.16 1.39 11.89 0.13 
H. incana 16.57 0.54 10.63 0.18 
H. involucrata 23.32 0.18 18.78 0.62 
H. lavandufolia 26.35 1.02 22.05 0.62 
H. muricata 29.21 1.96 21.62 0.91 
H. saccifera 15.41 0.65 12.94 0.56 
H. salviifolia >100  109.49 0.26 
H. scabra 15.40 0.43 12.77 0.20 
H. trifurca 42.66 0.35 41.74 0.99 
5,8- dihydroxy-6,7,4’- 
trimethoxyflavone 
>100    
cirsimaritin >100    
Ascorbic acid/ Trolox 2.46 0.01 2.96 0.001 
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Fig. 6.5: TLC plate sprayed with DPPH indicating compounds contained within each of the 
twelve plant extracts that possess free-radical scavenging activity.   
 
Fig. 6.6: TLC plate indicating antioxidant activity of isolated compounds, 5,8- dihydroxy-
6,7,4’- trimethoxyflavone (2), cirsimaritin (3) and H. saccifera (1). Only 5,8- dihydroxy-
6,7,4’- trimethoxyflavone of the isolated compounds produces slight activity. 
1 2 3 
2 3 4 5 6 7 8 9 10 11 12 1 
Legend: For all TLC 
plates 
 1 - H. salviifolia 
 2 - H. flammula 
 3 - H. holosericea 
 4 - H. cuneifolia 
 5 - H. althaeifolia 
 6 - H. lavandufolia 
 7 - H. saccifera 
 8 - H. involucrata 
 9 - H. incana 
 10 - H. muricata 
 11 - H. scabra 
 12 - H. trifurca 
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6.4. DISCUSSION: 
Ten of the twelve species indicated promising antioxidant activity in both the DPPH and 
ABTS assays with activity being dose-dependant such that increasing doses produced greater 
antioxidant activity. Since natural antioxidative substances usually have a phenolic moiety in 
their molecular structure (Dapkevicius et al., 1998), this suggests that these plants may have a 
high polyphenolic content such as tannins. Further research to explore the nature of these 
antioxidative compounds may yield interesting and possibly novel bioactive compounds. 
 
In contrast to the activity displayed by the other selected species, H. salviifolia indicated 
limited activity as a free radical scavenger. This may suggest low antioxidant content within 
the plant. This is interesting when it is noted that there appears to be no significant differences 
in the conservative HPLC profiles of H. salviifolia and that of H. cuneifolia, which displayed 
the greatest activity in both assays. In addition, TLC analysis of the extracts, again, does not 
display vital inclusions or exclusions of certain molecules between both species. It may be 
thus assumed that the differences in activity is not due to the content of antioxidant molecules 
within the plant but rather that of the quantity of molecules available to react, suggesting that 
H. salviifolia contains a lower quantity of  the same free radical scavengers than H. cuneifolia. 
Further work to identify and quantitate these compounds is thus essential in explaining the 
antioxidative ability of these plants. 
 
TLC analysis of the twelve species indicates that there are a number of compounds contained 
within each plant that possess activity. In addition, some of these compounds possessing 
activity are found in all species investigated, further, suggesting that the quantity of certain 
compounds contained within the plant is responsible for the activity. 
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When compared to the reference antioxidants (ascorbic acid and Trolox) the extracts exhibited 
lower activity. However, some extracts compared favorably to that of the reference 
compounds.  Furthermore, these are crude extracts and not isolated compounds such that they 
contain many compounds that do not contribute to the total antioxidant capacity of the 
extracts. Isolation of pure antioxidant compounds may provide results that indicate equal or 
greater free radical scavenging activity than that of the reference compounds. 
 
DPPH. and ABTS.+ are based on their ability to scavenge a proton from surrounding molecules 
resulting in a loss of color by the radical which decreases the absorbance of the solution. Since 
these assays have the same mechanism of reaction, it is reasonable to expect that the results 
obtained should be relatively similar allowing for experimental error. This is indicated in the 
results in which similarity between the two assays are evident. However, it is important to note 
that in most cases, the IC50 values in the ABTS assay are lower than those recorded in the 
DPPH assay.  The ABTS radical may react with a molecule that has electron- or H- donating 
potential (Pellegrini et al., 1999). The electron donors undergo a rapid reaction with ABTS.+ 
while the functional hydroxyl groups are slower reacting (Pannala et al., 2001). Thus, the 
ability of ABTS.+ to react via two mechanisms indicates that the activity displayed would be 
higher in this assay as compared to that of DPPH which reacts only via the acceptance of a 
hydrogen from a suitable donor. 
The isolated flavone compounds indicated limited activity in the DPPH assay with IC50 values 
greater than 100 µg/ml. It can be assumed due to the close resemblance of the mechanism of 
action that the assays would thus, have exhibited limited activity in the ABTS assay as well. In 
addition, TLC analysis indicates that only 5,8- dihydroxy-6,7,4’- trimethoxyflavone possess 
slight free radical scavenging activity while cirsimaritin does not appear to possess any 
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activity. This result is surprising considering that these compounds have a number of hydroxyl 
groups that may donate a hydrogen to partake in the reaction with the radical (Fig 6.4). In 
addition, studies conducted by Cuvelier et al. (1996), as measured by accelerated autoxidation 
of Methyl linoleate, have indicated that cirsimaritin is an effective antioxidant compound. 
However, both compounds contain only two hydroxyl groups and it has been shown that an 
increasing number of hydroxyl groups as well as the presence of a hydroxyl group at the 5’ 
position, which does not appear in the structure of these compounds, increases the antioxidant 
activity of flavonoid-type compounds such as flavones (Škerget et al., 2005). 
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Fig. 6.7: Structure of isolated flavone compounds, 5,8- dihydroxy-6,7,4’- trimethoxyflavone 
(1) and cirsimaritin (2). 
 
 
 
While the selected plant species indicate promising free radical scavenging activity, it must be 
noted, however, that there are a number of mechanisms by which antioxidants may function. 
The cascade leading to oxidative damage is complex and only free radical scavenging activity 
has been explored. Mechanism of antioxidant action can include suppressing reactive oxygen 
species formation, either by inhibition of enzymes or by chelating trace elements involved in 
1 2 
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free-radical production, scavenging reactive species, and up-regulating or protecting 
antioxidant defenses (van Acker et al., 1996). While these plants do possess chain breaking 
potential, a selection of assays may provide a more complete indication for the extent of 
antioxidant activity and therefore, assays such as the hydrogen peroxide, Thiobarbituric Acid 
Reactive Substances (TBARS), as well as iron-chelation assays may define the antioxidant 
ability further.  In addition, in vitro activity does not always correspond with activity in vivo 
and therefore, in vivo tests are required to verify this activity. 
 
6.5. CONCLUSION: 
Ten Hermannia species have indicated good in vitro antioxidant activity in both the DPPH and 
ABTS assays although the activity was less than that of the reference compound with the IC50 
values in the ABTS assay being lower possibly due to its ability to function via two 
mechanisms. In addition, the two flavone compounds investigated indicated negligible free 
radical scavenging activity which may be attributed to the presence of only a few hydroxyl 
groups on the structure of both compounds. When considering the traditional uses of these 
plants as listed in Chapter 1, it appears that a number have been employed to treat wounds and 
various skin afflictions. This indicates that antioxidant activity may play a vital role in the 
ability of Hermannia species to heal. In addition, neutrophil derived reactive oxygen 
intermediates, such as hydrogen peroxide and superoxide anions, are responsible for the 
pathogenesis of various inflammatory conditions (Fernandes et. al., 2004), suggesting the 
possible treatment of inflammation through their antioxidative abilities. Since the selected 
species have shown significant antioxidant activity, it may be speculated that one aspect of 
their healing properties may be through antioxidant activity. While this is only one aspect of 
the antioxidative cascade that is being investigated, the plants have indicated promising 
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activity which may be further explored in other antioxidant assays.  A correlation is indicated 
between the biological activity and traditional usage of these plants which are utilized in the 
treatment of many diseases associated with free radical activity.  
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CHAPTER 7 - ANTI-INFLAMMATORY ACTIVITY 
 
7.1. INTRODUCTION: 
The word inflammation is derived from the state of being inflamed. To inflame means to “set 
afire”. This conjures up the color red, a sense of heat and often pain. Inflammation is 
commonly divided into three phases: acute inflammation, the immune response and chronic 
inflammation (Katzung, 2001). It is controlled by the presence of a group of substances called 
chemical mediators, each with a specific role at some definite stage of the inflammatory 
reaction (Trowbridge and Emling, 1989). Histamine, serotonin, bradykinin, and the 
eicosanoids, prostaglandins and leukotrienes are some of the mediators, which are known as 
autacoids that are involved. The cell damage associated with inflammation acts on cell 
membranes to cause leukocytes to release lysosomal enzymes, which causes the liberation of 
arachidonic acid from precursor compounds.  
Arachidonic acid is the most abundant and probably most important of the precursors of 
eicosanoids. It is a 20-carbon fatty acid that contains four double bonds. For eicosanoid 
synthesis to occur, arachidonic acid must be first released or mobilized from the membrane 
phospholipids by one or more lipases of the phospholipase A2 type (Katzung, 2001).  
Arachidonic acid is present in the cell membranes in an esterified form. Release of arachidonic 
acid is thought to be the rate-limiting step in a multistage biosynthetic process, which is 
mediated by specific enzymes that begin the process by inserting molecular oxygen on 
arachidonic acid. The chain of eicosanoid biosynthesis begins with trauma, infection and 
inflammation (Henderson, 1994). Following mobilization, arachidonic acid is oxygenated by 
four separate routes: the cyclooxygenase, lipoxygenase, P450 epoxygenase, and isoprostane 
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pathways. The metabolism of arachidonic acid by 5-, 12-, and 15-lipoxgenase results in the 
production of hydroperoxyeicosatetranoic acids, which are rapidly converted to hydroxy 
derivatives and leukotrienes (Katzung, 2001).  
Membranes Phospholipids 
                                                          
Arachidonic Acid 
                    Cyclooxygenase Pathway                 Lipoxygenase Pathway 
 
                                 Prostaglandins                          Leukotrienes 
The metabolism of arachadonic acid by 5-lipoxygenase produces the biologically active 
leukotrienes which are involved in the mediation of various inflammatory disorders. They play 
a major role in the inflammation response to injury and have been implicated in the 
pathogenesis of several inflammatory diseases most noticeably asthma, psoriasis, rheumatoid 
arthritis and inflammatory bowel disease (Henderson, 1994). This pathway is of great interest 
since it is associated with asthma and anaphylactic shock. Stimulation of these inflammatory 
cells elevates intracellular Ca2+, releases arachidonic acid and incorporates molecular oxygen 
by 5-lipoxygenase to yield the unstable epoxide leukotriene A4 that may then be converted to 
cystennyl leukotrienes or peptidoleukotrienes (Katzung, 2001). 
The action of lipoxygenases generates compounds that can regulate specific cellular responses 
important in inflammation and immunity (Katzung, 2001). Certain leukotrienes cause 
adherence of neutrophils to the endothelium of postcapillary venules and are powerful 
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chemotactic agents while others cause vasodilation and increased venular permeability 
(Trowbridge and Emling, 1989).  
The role of leukotrienes as inflammatory mediators of disease has made them therapeutic 
targets and many inhibitors aimed at leukotrienes biosynthetic or effecter mechanisms are 
being developed (Henderson, 1994). Leukotrienes, thus, in addition to being an important 
factor in the promotion of asthma, is responsible for some of the symptoms of inflammation 
and, thus, inhibition of this enzyme may prove useful in the treatment of inflammation. 
 
7.2. METHOD 
7.2.1. Principle of the method 
This method for the inhibition of the 5-lipoxygenase enzyme was determined by Sircar et al. 
(1983) and further modified by Evans (1987). The spectrophotometric assay involves the 
detection of 5-lipoxygenase inhibitory activity of test compounds which results in the 
inhibition of formation of the conjugated diene of linoleic acid.  
 
The oxidation of unsaturated fatty acids containing 1-4 pentadiene structures is known to be 
catalyzed by 5-lipoxygenase. In the body, the biological substrate for 5-lipoxygenase is 
arachidonic acid which produces various eicosanoids that play a role in inflammation. 
However, 5-lipoxygenase enzyme is also able to interact with linoleic acid which was then 
chosen to be utilized in this in vitro assay due to its ease in handling. In addition, it has a 
stronger affinity for the 5-lipoxygenase enzyme resulting in an increase in the UV absorbance. 
5-lipoxygenase oxidizes linoleic acid to a conjugated diene. The modification of the 
unsaturation site of linoleic acid (1,4-diene to 1,3-diene) causes an increase in the absorption 
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at 234 nm. When inhibition occurs, the absorbance is decreased and can be correlated to 
inhibition of the 5-liopxygenase enzyme. 
 
7.2.2. Protocol 
A starting concentration of 100 µg/ml was obtained with each sample being dissolved in 
DMSO (Saarchem) and Tween® 20 (Merck). 10 µl of test sample was mixed with 2.95 ml of 
a 0.1 M potassium phosphate buffer (pH 6.3) and 45 µl of linoleic acid (≥ 99%, Fluka), all of 
which was placed in a 3 ml cuvette maintained at 25°C in a thermostat bath. The initiation of 
the reaction was produced through the addition of 100 U of 5-lipoxygenase (Cayman) which 
had been diluted with an equal volume of a 0.1 M potassium buffer (pH 6.3) that had been 
maintained at 4°C. The increase in absorbance at 234 nm was recorded for a period of ten 
minutes using a single beam spectrophotometer (Specord 40) utilizing Winaspect® software. 
The straight-line portion of the curve was used to determine the initial reaction rate and 
comparison with the negative control (DMSO and Tween® 20) produced the percentage 
inhibition of enzyme activity. Dilutions were made of samples that displayed activity from 
which the concentration that produces 50 % inhibition (IC50) of the enzyme was calculated 
using the Enzfitter® version 1.05 software. The experiment was conducted in duplicate i.e. N 
= 2. Nordihydroguaiaretic acid (NDGA) was used as a positive control. 
 
7.3. RESULTS: 
Table 7.1. indicates the inhibition of the 5-lipoxygenase enzyme by the various selected plant 
species. Eleven of the twelve plant species showed activity against 5-lipoxygenase enzyme 
ranging from 26.79 to 56.36 % of inhibition of the enzyme at 100 µg/ml with H. lavandufolia 
indicating the lowest activity. The only plant extract to portray good activity was H. 
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cuneifolia, which indicated 100 % inhibition at 100 µg/ml with an IC50 value of 15.32 ± 5.49 
µg/ml.   
 
Results for compounds isolated from various Hermannia species i.e. β-sitosterol, lupeol, 5,8- 
dihydroxy-6,7,4’- trimethoxyflavone and cirsimaritin indicated limited activity against the 
enzyme with an inhibition of 2.0 % and 40.0 % for β-sitosterol and lupeol respectively as well 
as 51.97 % and 33.86 % for 5,8- dihydroxy-6,7,4’- trimethoxyflavone  and cirsimaritin 
respectively.  
 
Fig 7.1 indicates the activity of all tested plant extracts and compounds in comparison 
indicating the extensive activity exhibited by H. cuneifolia and the limited activity of the other 
compounds in comparison. 
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Table 7.1: Inhibition of the 5-lipoxygenase enzyme by various species of Hermannia as well 
as compounds isolated from Hermannia species. 
Species/Compounds Inhibition (100 %) St. dev. IC50 (µg/ml) 
H. althaeifolia 56.53 0.23  
H. cuneifolia 100.0  15.32 ± 5.49 
H. flammula 44.77 0.96  
H. holoserisea 56.4 2.63  
H. incana 47.26 0.02  
H. involucrate 44.66 1.46  
H. lavandufolia 27.69 3.16  
H. muricata 32.11 0.87  
H. saccifera 45.8 4.65  
H. salviifolia 41.38 0.62  
H. scabra 33.07 0.00  
H. trifurca 51.97 2.23  
5,8- dihydroxy-6,7,4’- 
trimethoxyflavone 51.97 2.23  
Cirsimaritin 33.86 3.34  
Lupeol 42.5 3.54  
β-sitosterol 2.13 0.18   
Nordihydroguaiaretic acid 
(NDGA) 100  2.39 ± 0.71 
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Fig. 7.1: Bar chart indicating the percentage inhibition of the 5-lipoxygenase enzyme by 
Hermannia plant extracts as well as isolated compounds, 5,8- dihydroxy-6,7,4’- 
trimethoxyflavone, cirsimaritin, lupeol and β-sitosterol, at 100 µg/ml. 
 
7.4. DISCUSSION:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
The extracts displayed moderate inhibition of the 5-lipoxygenase enzyme with only H. 
cuneifolia indicating activity that was promising. This, however, does not correlate with 
complete lack of anti-inflammatory activity. It is important to recognize that this assay relates 
only to the production of leukotrienes and thus, the extracts may be active in other areas of the 
cascade of events implicated in the inflammatory process other than the formation of 
leukotrienes. Conclusive evidence would be required by investigating the effects of these 
plants in other assay such as the cyclo-oxygenase-1 (COX-1) assay or phospholipase A2 assay. 
Previous studies conducted on one species of this genus, Hermannia depressa, indicated good 
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inhibition of the COX-1 enzyme (Reid et al., 2005) and hence further investigation into this 
aspect of the inflammatory cascade may provide added insight into the anti-inflammatory 
action of Hermannia. In addition, the inhibition of leukotrienes by the plant extracts may also 
be related to the inhibition of the 5-lipoxygenase activating protein (FLAP). Studies have 
indicated that cells, which contain 5-lipoxygenase and not FLAP, are unable to biosynthesize 
leukotriene products unless provided with a large excess of exogenous arachidonic acid 
substrate and thus, the plant may exhibit this mechanism of action. Further, the direct 
inhibition of leukotriene D4 itself cannot be eliminated as this is another possible mechanism 
of action for the modulation of the pathway (Young, 1999). 
 
H. cuneifolia, in contrast, displayed good activity against the 5-lipoxygenase enzyme and 
exhibited a concentration dependant effect such that increasing concentrations of extract 
produced a greater inhibition of the 5-lipoxygenase enzyme. This suggests that there may be 
interesting compounds present in the plant that may be contributing to this activity. As shown 
in Chapter 6, H. cuneifolia also displayed good antioxidant activity. Since antioxidant and 
anti-inflammatory activities are often related (Fernandes et al., 2004), isolation may produce 
bioactive compounds that may be useful in treating inflammation as well as free radical 
scavenging activity. The formation of leukotrienes has been implicated in asthma and, 
therefore, isolation of these bioactive compounds may produce compounds that may be 
utilized in the treatment of these disease states. 
 
Isolation of compounds from H. cuneifolia produced two compounds, lupeol and β-sitosterol 
which have, previously, been implicated in anti-inflammatory activity in vivo (Geetha and 
Varalakshi, 2000; Awad et al., 2004). However, lupeol produced moderate activity against the 
5-lipoxygenase enzyme in vitro while the activity of β-sitosterol was negligible. These 
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compounds do contribute to the total activity of H. cuneifolia in the inhibition of the enzyme 
yet they are not the major contributors to the activity of the crude plant extract. It also suggests 
that there are a number of compounds, occurring within the plant, that may react collectively 
to produce the anti-inflammatory activity observed.  
 
Lupeol has previously been shown to exhibit good anti-inflammatory activity in the 
carrageenan and 12-O-tetradecanoylphorbol-13-acetate induced models of inflammation 
(Arciniegas et al., 2004) and the limited activity indicated by the compound is thus surprising. 
Studies into the mechanism of anti-inflammatory action of lupeol have indicated that its action 
is dependant on its ability to prevent the production of some pro-inflammatory mediators. 
However, it was shown that lupeol dose-dependently inhibited the production of PGE2 but did 
not exhibit any significant effect on LTC4 release, which strongly suggested that the triterpene 
did not affect the 5-lipoxygenase pathway (Fernádez et al., 2001). Hence, the moderate 
activity of lupeol in the 5-lipoxygenase assay was understandable and further, confirms that 
lupeol may not affect leukotriene synthesis in its anti-inflammatory action. 
 
In addition, the two flavones isolated from H. saccifera exhibited moderate inhibition of the 5-
lipoxygenase enzyme with the flavone, 5,8- dihydroxy-6,7,4’- trimethoxyflavone, producing 
the best inhibition (51.97 % at 100 µg/ml). This indicates that these compounds contribute to 
the total inhibition of 5-liopxygenase by H. saccifera and are possible major contributors to 
this activity since the activity of 5,8- dihydroxy-6,7,4’- trimethoxyflavone is greater than that 
of the plant extract (45.8 %). However, further work must be undertaken as it is important to 
investigate either the synergistic or antagonistic activity of the compounds in order to 
determine their total effect on the inhibition of 5-lipoxygenase enzyme.  
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Yoshimoto et al. (1983) reported that certain flavonoids were potent and relatively selective 
inhibitors of the 5-lipoxygenase enzyme. However, it was determined that certain structural 
characteristics are necessary to produce potent activity. Flavones with no substituents would 
have limited activity. A cathechol structure (i.e. a vicinal diol at R5 and R6) in ring B appeared 
necessary to inhibit the 5-lipoxygenase enzyme. Further modification of the 5-OH group (R1) 
decreases the inhibitory effect as well as the demethylation at position 7 (R3) reduces the 
inhibitory effect of the flavones. The structural components of 5,8- dihydroxy-6,7,4’- 
trimethoxyflavone and cirsimaritin (Fig. 7.3) indicates most structural requirements are 
present thus, causing some activity. However, a lack of the cathechol structure in ring B is a 
possible reason for the moderate activity observed. 
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Fig. 7.2: Structure of a flavone. 
 
 
O
 MeO 
MeO 
 OMe
 H
OOH
 
OH
 
1
2
3
45
6
7
8
9
10
1'
2'
3'
4'
5'
6'
  
O
 MeO 
MeO 
 OH
 H
OOH
H
 
1
2
3
4
5
6
7
8
9
10
1'
2'
3'
4'
5'
6'
 
Fig. 7.3: Structure of isolated flavone compounds, 5,8- dihydroxy-6,7,4’- trimethoxyflavone 
(1) and cirsimaritin (2). 
1 2 
  
137 
7.5. CONCLUSION: 
The selected species of Hermannia investigated do not possess significant activity against the 
5-lipoxygenase enzyme with the exception of H. cuneifolia where promising activity has been 
recorded. Further, compounds isolated from Hermannia species displayed limited inhibition 
against the enzyme. However, further work is necessary to determine the actual compounds 
possessing activity as well as to quantify them in all species to determine whether the amount 
of compound contained within the plant is a major contributor. In addition, while the plant 
extracts do not portray good activity in this assay we cannot exclude the possibility that the 
plants do have anti-inflammatory activity, which may be displayed at other events in the 
inflammatory cascade. The selected species of the genus, Hermannia are utilized in the 
treatment of a number of disease states, such as wounds, sores burns as well as hemorrhoids. 
Therefore, the anti-inflammatory effect portrayed by the plants may be only one aspect of the 
healing ability and the effect of the plants on healing may be observed at various therapeutic 
levels. In addition, they are also utilized in the treatment of respiratory conditions such as 
asthma, in which the ability to inhibit the 5-lipoxygenase is an important aspect.  
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CHAPTER 8: ANTIMALARIAL ACTIVITY AND TOXICITY STUDIES 
 
8.1. INTRODUCTION: 
 
8.1.1. Malaria 
Of all the human afflictions, the greatest toll has been exacted by malaria. Even today, 
malaria, which is caused by the protozoan parasites of the genus Plasmodium, infects and kills 
more people than any other infectious disease. Every year it causes clinical illness, often very 
severe, in 300-500 million people, 1.5-2.7 million of whom die. At present, some 90 countries 
or territories in the world are considered malarious, with almost half of them located in Africa 
south of the Sahara (Sherman, 1998).  
Infection with any of the four species of Plasmodia, resulting in periodic paroxysms of chills, 
fever and sweating, anemia and splenomegaly, is the cause of the disease known as malaria. 
Transmission begins when a female Anopheles mosquito feeds on a person with malaria and 
ingests blood-containing gametocytes. During the following one to two weeks, gametocytes 
inside the mosquito reproduce sexually and develop into infective sporozoites. When the 
mosquito feeds on a human, it inoculates sporozoites, which quickly infect the host’s 
hepatocytes. This does not produce clinical illness. However, schizogony occurs within 
infected hepatocytes; one to two weeks later they rupture and release merozoites that invade 
the red blood cells and there transform into rings and trophozoites. These young trophozoites 
grow and develop into schizonts, which then rupture the red blood cell resulting in anaemia, 
jaundice and eventual death (Beers and Berkow, 1999). Fig. 8.1 illustrates the simplified life 
cycle of P. falciparum. 
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Fig. 8.1: Life cycle of P. falciparum in the human host (Baird, 2005). 
 
Over the past 20 years, efforts to control malaria have been less successful (Sherman, 1998). 
This is largely due to the development of resistance by the malaria parasite to nearly all the 
antimalarial drugs used for prophylaxis and treatment, particularly in P. falciparum (Nwaka et 
al., 2004). Since the treatment and control of malaria depends largely on a limited number of 
chemoprophylactic and chemotherapeutic agents, there is an urgent need to develop novel, 
affordable antimalarial treatments. Historically, the majority of antimalarial drugs have been 
derived from medicinal plants or from structures modeled on plant lead compounds. These 
include the quinoline-based antimalarials, as well as artemisinin and its derivatives.  
Medicinal plants are commonly used in South African traditional healthcare to treat a range of 
ailments, including malaria and its associated symptoms (Clarkson et al., 2004). Traditional 
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medicine is, therefore considered as a rich source of potential drugs for the treatment of fevers 
and malaria and thus it seems worthwhile to examine these plants closely using modern 
scientific methods (François et al., 1996). To contribute towards this desperate need for further 
life-saving treatment, Hermannia species were systematically investigated for antimalarial 
activity. 
8.1.2. Toxicity 
It is difficult to believe that the ‘green world’ is not entirely friendly. However, a surprisingly 
large number of plants contain toxic substances that can kill any creature that eats enough of 
them (Dowden, 1994). Most common herbal remedies are fairly safe in clinical use, not 
because they are ‘natural’, but because the long history of use has uncovered some of the side 
effects. Traditional use, however, is not always a reliable indication of safety and, because 
many patients do not consider phytomedicines to be ‘drugs’, an association may not have been 
made between the remedy and the problem. Alternatively a long interval between taking the 
medicine and the onset of a reaction may make the connection difficult (Heinrich et al., 2004). 
In South Africa, poisoning by traditional remedies especially those obtained from plants is 
well documented (Steenkamp, 2000). Cases of acute poisoning due to traditional medicines 
are not uncommon, many of which have resulted in significant morbidity and mortality, with 
mortality estimated to be as high as 10,000 to 20,000 per annum (Popat et al., 2001). Only a 
few plants found in traditional medicines contain pharmaco-active chemicals that are toxic. 
However, these seem to make a significant contribution to morbidity and mortality 
(Steenkamp, 2000).  
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The extensive use of traditional medicines in South Africa indicates an urgent need to ensure 
that many of these plants, that are utilized, do not contain phytochemicals that make them 
hazardous for use and for this reason identification of potential toxicity of medicinal herbs has 
been identified as a top research priority. In addition, should these plants possess extensive 
biological activity, this data is necessary in assessing the possibility of developing a drug from 
the natural source. 
8.2. METHODS:  
 
8.2.1. Antimalarial activity 
Antimalarial activity of all twelve of the selected species of Hermannia was assessed in vitro 
using the titrated hypoxanthine incorporation assay (Desjardins et al., 1979; van Zyl and 
Viljoen, 2002). Methanol extracts were made of all plants and were dissolved in dimethyl 
sulphoxide (DMSO) to a concentration of 10 mg/ml. 
8.2.1.1. Principle of assay 
DNA and RNA are polymers of nucleotides. Nucleotides consist of a ribose sugar group 
linked to either a purine (adenine and guanine) or a pyrimidine (cytosine, uracil, and thymine) 
base. These bases can either be obtained via de novo synthesis or from the environment by the 
'salvage' pathway. The malarial parasite obtains preformed purines by the salvage pathway and 
synthesizes pyrimidines de novo.  
The primary purine salvaged by the parasite is hypoxanthine which can be obtained from the 
host plasma. Hypoxanthine is a naturally occurring purine derivative which is present in 
inosine monophosphate from which adenosine monophosphate and guanosine monophosphate 
are made. Malaria parasites (P. falciparum) grow and replicate in human red blood cells.  This 
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stage of their life cycle results in the morbidity and mortality associated with the disease.  
Replication depends on available sources of purine and pyrimidine precursors for DNA and 
RNA synthesis.  While parasites are able to synthesize pyrimidines de novo, they depend 
entirely on their host for pre-formed purines.  Previous work showed that hypoxanthine is the 
preferred form of purine utilized by growing parasites (Berman et al., 1991).  
Desjardins et al. (1979) developed an in vitro drug-sensitivity assay based on the incorporation 
of tritiated-labeled hypoxanthine. This method is based on the inhibition of uptake of a 
radiolabeled nucleic acid precursor (hypoxanthine) during short term cultures in microtitration 
plates. Hypoxanthine is only incorporated into living cells thus, if the plant extract is active 
against the Plasmodium the protozoa will die and thus no hypoxanthine will be incorporated 
and therefore a lower value will be obtained. Inhibition of uptake of the radio labeled nucleic 
acid precursor by parasites, thus serves as an indicator of antimalarial activity. 
 
8.2.1.2. Protocol 
8.2.1.2.1. Culturing of parasites 
 The parasite strain used in these experiments was an isolate of a chloroquine-resistant P. 
falciparum - FCR-3 (van Zyl and Viljoen, 2002). The parasites were continuously maintained 
in a 5 % suspension of human erythrocytes with a culture medium consisting of 10.4 g/L 
RPMI–1640, 5.9 g/L HEPES (N-2-hydroethylpiperazine-N’-2-ethanesulfonic acid), 4.0 g/L 
glucose, 44 mg/L hypoxanthine and 50 mg/ml gentamicin sulphate, which was supplemented 
by 10 % (v/v) human plasma and 5 % (w/v) sodium bicarbonate. The culture medium was 
filtered through a Sterivex–GS 0.22 µm filter unit before use to ensure sterility. The plasma 
was heat inactivated at 56°C in a water bath for 2 hours before being centrifuged at 3000 rpm 
for 20 min after which it was stored at -20˚C. Citrate phosphate dextrose adenosine-1 was 
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added to prevent coagulation of red blood cells. Cultures containing predominantly early ring 
stages were used for drug-sensitivity testing. Cultures were synchronized every second day 
using a 5 % (w/v) D-sorbitol solution (Lambros and Vanderberg, 1979). Cells were cultured at 
37°C with fresh erythrocytes added every second day. Cells were maintained at less than 5 % 
infected with parasites. 
 
Blood was obtained from the South African National Blood Services. Before use blood was 
washed three times in phosphate buffer saline (PBS, pH 7.4) by centrifugation at 2000 rpm for 
5 min after which the buffy coat and serum were discarded. PBS consisted of NaCl (8.0 g), 
KCl (0.3 g), Na2HPO4.2H2O (0.73 g) and KH2PO4 (0.2 g) dissolved in 1 L sterile MilliQ® 
water and was autoclaved. The erythrocytes were then suspended in experimental medium 
(hypoxanthine and gentamicin deficient culture medium) to prevent dehydration and stored at 
4°C.   
 
8.2.1.2.2. Hypoxanthine incorporation assay 
A 96-well microtitre plate was used to measure antimalarial activity. The plates and parasites 
were prepared using strict aseptic techniques inside a laminar flow hood. Each dilution of 
extract (25 µl) was plated out in triplicate. Parasite suspension (200 µl) that had been adjusted 
to 0.5 % parasitaemia and 1 % of haematocrit, was added to the wells containing the extract. 
To prepare the drug-free parasite control, 200 µl of parasites were added to 8 wells containing 
no extract. A 1 % solution of red blood cells (RBC) that were parasite free were added to 4 
wells and served as the non-parasitized erythrocyte control. Hypoxanthine-free media (25 µl) 
was added to these wells to ensure that the volume in each cell was correct. The plate was then 
incubated at 37°C in a humidified candle jar for 24 hours.   
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Radio labeled [3H]-hypoxanthine (10 µl/plate) (5 mCi) (Amersham, UK) stabilized in 
ethanol:water (1:1, v/v) solution was 50 % evaporated off and 2.7 ml experimental media was 
added to adjust to 18 µCi. The isotope (25 µl) was added to each well and the plate was 
incubated for a further 24 hours. The parasite DNA was then harvested on GFB-filtermats 
with a Titertek® cell harvester. The filtermats were then dried and the incorporated [3H]-
hypoxanthine was measured in counts per minute (cpm) by a liquid beta scintillation counter 
determined  
 
Percentage parasite growth of untreated parasitized and erythrocyte controls were used to 
express the inhibitory effects of the plant extracts on the malaria parasite. 
 
     % Parasite Growth = ____(Plant extract) cpm – (Mean RBC control) cpm___   
                                       (Mean Parasite control) cpm – (Mean RBC Control) cpm                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
 
Logarithmic transformation of the concentration allowed sigmoid-dose response curves to be 
plotted from which the IC50  value i.e. the concentration required to inhibit 50 % of parasite 
growth, was obtained using the Enzfitter® software. The plant extracts were replicated in 
triplicate to ensure accuracy of results.  
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8.2.2. Toxicity testing 
 
8.2.2.1. Principle of assay 
The measurement of cell viability and growth is a valuable tool in a wide range of research 
areas. Viable cells can be measured by using any of several staining methods. Ideally a 
colorimetric assay for living cells should utilize a colorless substrate that is modified to a 
colored product by any living cell but not dead cells or tissue culture medium. Tetrazolium 
salts are attractive candidates for this purpose since they measure the activity of various 
dehydrogenase enzymes. The tetrazolium ring is cleaved in active mitochondria, and so the 
reaction occurs only in living cells (Mosmann, 1983). The 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide (MTT) cell proliferation assay is a rapid colorimetric test based 
on the tetrazolium salt, MTT. This is a yellow salt which is reduced in metabolically active 
cells to form insoluble purple formazan crystals, which are solubilized by the addition of 
DMSO. The color can then be spectrophotometrically quantified. For each cell type a linear 
relationship between cell number and absorbance is established, enabling accurate 
quantification of changes in proliferation. 
8.2.2.2. Protocol 
Transformed human kidney epithelium (Graham) cells were used to test the toxicity of the 
various plant extracts using the MTT colorimetric microtitre plate method developed by 
Mosmann (1983). Extracts were made up to 10 mg/ml solutions in DMSO from which further 
dilution were made. 
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8.2.2.2.1. Culturing of cells 
The culture medium containing Ham F10 solution (9.38 g of Ham’s F10 medium and 1.18 g of 
NaHCO3 in 1 L of sterile water), 5 % fetal calf serum (inactivated at 56°C for 1 hour) and 50 
mg/ml gentamicin sulfate was utilized to maintain the Graham cells. The culture medium was 
replaced every second day. 
 
8.2.2.2.2. MTT cell proliferation assay 
When cells had reached confluency, they were trypsinised using 4 ml of 0.25 % Trypsin/0.1 % 
Versene EDTA that was at 25°C. Experimental medium (containing Ham F10 solution (9.38 g 
of Ham’s F10 medium and 1.18 g of NaHCO3 in 1 L of sterile water), 5 % fetal calf serum 
(inactivated at 56°C for 2 hours) was then added and a single cell suspension of the cells was 
obtained. One milliliter of the suspension was used to reseed the culture, while the rest was 
utilized in the MTT assay. The cell density was assessed by staining them with Tryptan Blue 
in a 1:1 ratio and then counted with a haemocytometer. A 95 % cell viability was ensured 
before use of cells. The cell suspension was diluted using experimental medium to 0.25 
million cells per milliliter and 180 µl of this suspension was added to the 96-well microtitre 
plate. The plate was incubated under a humidified environment at 37°C with 5 % CO2 for six 
hours to allow the cells to adhere to the bottom of plates. The different concentrations of 
extracts (20 µl) were plated out in triplicate. DMSO was added to ten wells with no extract 
being added and this served as the cell control, while two wells served as the cell-free control 
with only experimental medium and DMSO added to these wells. The plates were incubated 
for 44 hours after which 40 µl of a 240 mM MTT solution prepared in PBS buffer (section 
8.2.1.2.1) was added to each well. Thereafter the plate was incubated for a further 4 hours. The 
supernatant (180 µl) from each well was removed and 150 µl of DMSO added to stop the 
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reaction as well as solubilize the formazan crystals. The plates were shaken at 1020 rpm for 4 
min and the absorbance read at 540 and 690 nm using a microplate reader (Labsystems iEMS 
Reader MF) and Ascent® software. The results were expressed as percentage cellular viability 
of the drug and cell-free controls. Sigmoid dose-response curves were obtained after 
logarithmic transformation of the concentration using the Enzfitter® software from which the 
IC50 values were obtained. The extracts were tested in triplicate. To determine selectivity of 
the extracts for the parasite and the relative toxicity profile of the extracts, the safety index 
was calculated by the following formula: 
 
 
                               Safety Index =   ____ Toxicity (IC50)_____ 
                                                         Antimalarial Activity (IC50) 
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8.3. RESULTS: 
 
The antimalarial and toxicity profiles for Hermannia are listed in Table 8.1. The safety 
indexes are included for species, H. saccifera and H. trifurca. Most species indicated moderate 
antimalarial activity with H. muricata, H.saccifera and H. trifurca showing any promising 
activity. H. trifurca exhibited the best activity with an IC50 value of 18.806 ± 1.113 mg/ml 
which is 553 fold less active than quinine as seen in Fig 8.2.  
 
The results obtained for toxicity indicate that most species investigated have an IC50 value that 
is >200 µg/ml. Only two species indicated a value lower than 100 µg/ml with H. saccifera and 
H. trifurca being 61.403 ± 4.56 and 75.613 ± 6.11 µg/ml, respectively. However, the safety 
index for both species is considerably lower than that of the controls with H. saccifera and H. 
trifurca having a safety index of 2.426 and 4.021 respectively. In comparison, the controls, 
chloroquine and quinine have a safety index of 2092.67 and 4001.76, respectively. 
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Fig. 8.2: Sigmoid-dose response curves for H. saccifera, H. trifurca and quinine.  
 
 
Table 8.1: Antimalarial activity, toxicity profile and safety index for selected species of 
Hermannia in µg/ml. 
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Species 
Antimalarial activity Toxicity profile Safety index 
 
IC50 s.d.* n* IC50 s.d.* n*  
H. althaeifolia 58.49 3.96 3 >200  3  
H. cuneifolia 50.67 2.96 3 >200  3  
H. flammula 55.84 2.62 3 >200  3  
H. holosericea 52.35 2.12 3 >200  3  
H. incana 68.13 1.81 3 >200  3  
H. involucrata 46.08 3.23 3 >200  3  
H. lavandufolia 70.38 3.98 3 >200  3  
H. muricata 28.17 3.72 3 >200  3  
H. saccifera 25.30 0.96 3 61.403 4.56 3 2.43 
H. salviifolia 64.38 2.16 3 >200  3  
H. scabra 88.57 2.41 3 >200  3  
H. trifurca 18.80 1.11 3 75.613 6.11 3 4.02 
Chloroquine 0.06 0.003 6 125.56 5.04 3 2092.67 
Quinine 0.03 0.002 6 136.06 4.06 3 4001.77 
 
* s.d. = standard deviation 
   n = number of times experiment was replicated 
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Fig. 8.3: Bar chart indicating antimalarial activity of twelve Hermannia plant extracts and 
reference compounds (IC50) as well as indicating standard deviation.  
8.4. DISCUSSION: 
 
The results indicated that there was a concentration-dependant activity with an increasing 
concentration producing greater activity in the tritiated hypoxanthine incorporation assay (Fig 
8.2). However, the activities portrayed by the various species were not promising with only H. 
trifurca indicating any promising activity (Fig 8.3.; Table 8.1). This suggests that H. trifurca 
may be a suitable species for further phytochemical investigation. 
 
Most species of Hermannia appeared to be relatively non-toxic as most species displayed IC50 
values greater than 200 µg/ml. However, the two species, H. saccifera and H. trifurca, that 
indicated greater toxicity are also those species that showed activity in the antimalarial assay. 
These plants portrayed a concentration dependant effect with increasing concentrations 
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causing increasing cell death. This possibly indicates that the antimalarial activity is not 
specific for these plants, but rather their activity is based on a general toxicity of living cells 
which is highlighted by the low safety index displayed in Table 8.1. The identification of 
compounds that are active may provide further evidence or explanations of the relationship 
between activity and toxicity of these species. 
  
H. saccifera has previously indicated excellent activity against a number of micro-organisms 
in the antimicrobial activity assays (Table 5.2.). This activity may be related to the toxicity and 
non-specific cell-death that is caused by these plants. Identification of active compounds 
present in H. saccifera is essential to obtain a clearer understanding of the wide spectrum of 
activity that is displayed by this plant. In addition, further studies on these compounds should 
establish possibilities of the use of the compounds in the treatment of microbial diseases 
relating to safety of their use. 
 
H. muricata has displayed antimalarial activity with an IC50 value of 28.176 µg/ml. In addition 
the toxicity profile indicates that the IC50 value is >200 µg/ml with a safety index of >7.098 
(Table 8.1.). The safety index is higher than that of the other two active species and while still 
being lower than the controls, the accurate value may yield increased safety data, suggesting 
that this activity may be more specific to the malaria parasite than the other species tested. 
Further, H. muricata has not shown good antimicrobial activity further suggesting that this 
activity is more specific to the Plasmodium parasite. This requires further investigation to 
determine the active compounds and their potential toxicity as this species may yield novel 
drugs or drug templates with novel mechanisms of action against the parasite which will be of 
importance as the development of resistance by the parasite to current treatments spirals.  
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Only one species of Hermannia has previously been assayed for its antimalarial activity, i.e. 
Hermannia depressa (Clarkson et al., 2004). The assay utilized in assessing the activity was 
the parasite lactate dehydrogenase assay in which it produced an IC50 value of 6.9 µg/ml. The 
IC50 values obtained for the various species investigated is considerably higher than this value. 
While the differences in the assay utilized could be contributing to the variation in values, it 
can be seen that certain Hermannia species have greater anti-malarial activity than others. 
Hence, it is necessary to determine the active compounds in these species to determine if one 
or more different compounds contribute to the activity in the various species. 
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8.5. CONCLUSION: 
 
The various species of Hermannia investigated have indicated a degree of antimalarial activity 
with only H. saccifera, H. muricata and mostly H. trifurca possessing any promising activity. 
The toxicity testing of the various species indicates the species are fairly safe with the majority 
of species having an IC50 of >200 µg/ml. The safety index however indicates that the activity 
obtained by H. saccifera and H. trifurca have a non-specific action causing the death of any 
cell including healthy cells. On the otherhand, H. muricata appears to be of greater interest, as 
it is considerably less toxic with substantial activity and thus, further investigation is required. 
These species are often used to treat symptoms such as fevers, which in Africa are often 
related to or are used as a description of malaria. While the species do not portray extensive 
activity and an activity which may be non-specific, certain species have displayed good 
activity against Plasmodium falciparum. Further, the lack of in vitro activity should not 
disqualify the use of the plants as traditional antimalarials. While plant extracts may not 
display in vitro activity they may display in vivo activity in that the active compounds may 
require in vivo activation such as artemisinin. Therefore, it is necessary to undertake in vivo 
tests before a conclusion can be reached (Muregi et al., 2003). Finally, although limited 
activity was portrayed, there is some scientific basis for the traditional use of this plant in the 
treatment of malaria as well as further indicating that traditional use of plants have over the 
centuries managed to determine which plants are safe as well as active, substantiating the use 
of the plants. 
  
  
156 
8.6. REFERENCES: 
 
Baird, J.K. (2005) Effectiveness of antimalarial drugs. The New England Journal of Medicine 
352: 1565-1577 
 
Beers, M.H., Berkow, R. (1999) The Merck Manual of Diagnosis and Therapy. 17th edition. 
Merck Research Laboratories. U.S.A 
 
Berman, P.A., Numan, C., Freese, J.A. (1991) Xanthine oxidase inhibits growth of 
Plasmodium falciparum in human erythrocytes in vitro. Journal of Clinical Investigation 88: 
1848-1855 
 
Clarkson, C., Maharaj, V.J., Crouch, N.R., Grace, O.M., Pillay, P., Matsabisa, M.G., 
Bhagwandin, N., Smith, P.J., Folb, P.I. (2004) In vitro antiplasmodial activity of medicinal 
plants native to or naturalized in South Africa. Journal of Ethnopharmacology 92: 177-191 
 
Desjardins, R.E., Canfield, C.J., Haynes, D.J., Chulay, J.D. (1979) Quantitative assessment of 
antimalarial activity in vitro by a semiautomated microdilution technique. 
Antimicrobial Agents and Chemotherapy 16: 710-718  
 
 
Dowden, A.O. (1994) Poison in our Path: Plants that Harm and Heal. 1st edition. Harper 
Collins Publishers. New York 
François, G. Aké Assi, L., Holenz, J., Bringmann, G. (1996) Constituents of Picralima nitida 
display pronounced inhibitory activities against asexual erythrocytic forms of Plasmodium 
falciparum in vitro. Journal of Ethnobotany 54: 113-117 
  
157 
Heinrich, M., Barnes, J., Gibbons, S., Williamson, E.M. (2004) Fundamentals of 
Pharmacognosy and Phytotherapy. Elsevier Science Limited. Spain 
Lambros, C., Vanderberg, J.P. (1979) Synchronization of Plasmodium falciparum erythrocytic 
stages in culture. Journal of Parasitology 65: 418-420 
Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to 
proliferation and cytotoxicity assays. Journal of Immunological Methods 65: 55-63 
Muregi, F.W., Chabra, S.C., Njagi, E.N.M., Lang’at_Thoruwa, C.C., Njue, W.M., Orago, 
A.S.S., Omar, S.A., Ndiege, I.O. (2003) In vitro antiplasmodial activity of some plants used in 
Kisii, Kenya against malaria and their chloroquine potentiation effects. Journal of 
Ethnopharmacology 84: 235-239 
Nwaka, S., Riopel, L., Ubben, D., Craft, J.C. (2004) Medicines for malaria venture new 
developments in antimalarials. Travel Medicine and Infectious Disease 2: 161-170 
Popat, A., Shear, N.H., Malkiewicz, I., Stewart, M.J., Steenkamp, V., Thomson, S., Neuman, 
M.G. (2001) The toxicity of Callilepis laureola, a South African traditional herbal medicine. 
Clinical Biochemistry 34: 229-236  
Sherman, I.W. (1998) Malaria Parasite Biology, Pathogenesis and Protection. American 
Society for Microbiology. United States of America 
Steenkamp, V. (2000) Analytical and clinical studies of toxicity caused by traditional South 
African medicines. PhD thesis. University of the Witwatersrand. South Africa 
  
158 
van Zyl, R.L., Viljoen, A.M. (2002) In vitro activity of Aloe extracts against Plasmodium 
falciparum. South African Journal of Botany 68: 106-110 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
159 
CHAPTER 9: GENERAL CONCLUSION 
 
• TLC analysis indicated that the species are chemically uniform with only H. saccifera 
having differences in composition. HPLC results, further, indicated conservative 
profiles with similar profiles being produced by all species being investigated.  
 
• Isolation of compounds from H. saccifera produced a novel labdane-type compound, 
E-17, 19-diacetoxy - 15 - hydroxylabda - 7,13 - diene. In addition, two known flavone 
compounds, 5,8- dihydroxy-6,7,4’- trimethoxyflavone and cirsimaritin, were isolated. 
HPLC analysis indicates that the two flavone compounds occur in H. saccifera only. 
This is the first report of the presence of these compounds in Hermannia species. 
 
• All twelve species exhibited antimicrobial activity. The most promising activity was 
displayed by H. saccifera from which bioguided fractionation yielded the active 
diterpene, E-17, 19-diacetoxy - 15 - hydroxylabda - 7,13 - diene. The compound 
displays promising activity (23.6 µg/ml against S. aureus) which, although higher MIC 
values were determined than the crude plant extract (19.5 µg/ml against S. aureus), 
may be a possible lead compound in the search for new potent antibacterial 
compounds.  
 
• The death kinetics assay conducted on the crude extract of H. saccifera indicated that 
this activity is bacteriostatic rather than bactericidal with only high concentrations 
(0.75 %) indicating bactericidal activity. 
• Potential free radical scavenging activity was exhibited by ten of the twelve species 
investigated in both the DPPH and ABTS assays. The ABTS results were found to be 
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consistently higher due to its ability to function via two mechanisms. H. cuneifolia 
displayed the most promising activity (IC50 = 10.26 µg/ml in DPPH assay). 
Surprisingly, the two flavone compounds investigated had negligible free radical 
scavenging activity which may be due to the presence of fewer hydroxyl groups 
present on the molecule. 
 
• The Hermannia species investigated displayed limited inhibition of the 5-lipoxgenase 
enzyme with the exception of H. cuneifolia with produced good activity (IC50 = 15.32 
µg/ml). The two flavones as well as lupeol and β-sitosterol that have been isolated 
indicate moderate activity in the assay, indicating that these compounds do contribute 
to the activity of the plant extracts. The flavone compounds, in addition, lack chemical 
structural features that are required to potentiate the inhibition of the 5-lipoxygenase 
enzyme. 
 
• Hermannia species displayed moderate antimalarial activity with only H. saccifera, H. 
muricata and mostly H. trifurca possessing good activity. However, toxicity studies 
indicate that the activity of H. saccifera and H. trifurca may be due to a non-specific 
destruction of cells including healthy cells. H. muricata, thus, may be a potential 
source of antimalarial compounds due to its superior activity in the antimalarial assay 
as well as the favorable safety index. 
 
• The biological activity observed in Hermannia species provides a scientific basis for 
the use of the plants in traditional medicines with each facet of activity contributing to 
the ultimate healing ability of the plant. 
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Recommendations for further work 
• HPLC should be conducted using a detector which will be able to detect compounds 
that are poor chromophores. A refractive light or electrochemical detector may be 
useful. 
 
• Further isolation is required to determine compounds producing the various biological 
activities portrayed by the plant and the activity of these compounds require 
quantification. In addition, the synergistic or antagonistic properties of these 
compounds should be determined. 
 
• The chemical structure of E-17, 19-diacetoxy - 15 - hydroxylabda - 7,13 - diene should 
be reinvestigated to determine the structural-activity relationships of the compound and 
then compound manipulation may be utilized to improve the antimicrobial activity of 
the compound. In addition, the compound should be investigated for biological 
activities other than antimicrobial activity to determine the full spectrum of its use in 
the process of healing. However, more material is first required to record the physical 
data as well as to determine the toxicity of these compounds. 
 
• Antioxidant activity may be displayed by various mechanisms and hence the plant 
extracts should be investigated in other assays to determine if the activity is limited to 
free radical scavenging ability. In addition, active compounds should be quantitated 
within each plant species. 
 
• While plant extracts indicated limited inhibition of the 5-lipoxygenase enzyme, there 
are many events in the inflammation cascade that may be interrupted, hence decreasing 
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the symptoms of inflammation in the body. The plants should be investigated using 
different assays that assess other events in the cascade. 
 
 
 
 
 
 
 
 
 
 
 
 
  
163 
APPENDIX I 
 
Hermannia: Antibacterial Activity and Phytoconstituents of Selected 
Species of a Previously Unresearched Genus Used in Traditional Medicine 
 
Ayesha B. Essop*1, Alvaro M. Viljoen1, Dulcie A. Mulholland2, Sandy F. van Vuuren1, 
Chantal Koorbanally2. 
1Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the 
Witwatersrand, Johannesburg, 2001. 
2 Natural Products Research Group, School of Chemistry, University of KwaZulu-Natal, Durban, 4041 
 
PURPOSE: 
To evaluate the antibacterial activity of selected species of the genus, Hermannia, and to 
isolate and identify the bioactive compounds, as well as other phytoconstituents present within 
the various species. 
 
METHODS: 
Ten species of Hermannia were chosen due to their widespread use in traditional medicine. 
Plants were collected and crushed into powder. Acetone was used to obtain extracts from 5mg 
of powder of all selected species. Broad screen assays were carried out using the disc diffusion 
method on the following bacteria: Staphylococcus aureus, Baccilus cereus, Escheria coli. 
500g of active species were then extracted using acetone and were fractionated using column 
chromatography firstly in groups sharing similar physicochemical characteristics. Bioguided 
fractionation, column chromatography and preparative thin-layer chromatography were 
utilized to isolate bioactive compounds. Pure compounds were characterized using NMR 
spectroscopy. 
500g of certain species were selected, based on traditional use, were extracted using 
dichloromethane: methanol (1:1). Some phytoconstituents were isolated and characterized 
using methods described above. High performance liquid chromatography was used to 
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evaluate the compounds present in all species and ultra-violet spectrums were compared for 
similarities. 
 
RESULTS: 
Of the ten species selected, two species viz. H. althaeifolia and H. cuneifolia were found to be 
antibacterially active. Isolation using bioguided fractionation supplied interesting aromatic 
compounds. Active compounds were confirmed using bioautographic assays and disc 
diffusion.  
Species were found to be similar in character with regard to phytoconstituents present. 
 
CONCLUSIONS: 
Hermannia is a genus that is widely used in traditional medicine for ailments such as 
respiratory infections. The results indicate that certain species are antibacterially active and 
isolated compounds have potential use in this area. Thus, potentially, this neglected genus may 
be, extensively pharmacologically active.  
The similarity of phytoconstituents within the selected species suggests a possibility of similar 
compounds across the board within the species of the genus. 
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APPENDIX II 
 
Hermannia: The Biological Activity and Phytoconstituents of an Unexplored 
Genus Used in African Traditional Medicine 
 
Ayesha B. Essop*1, Alvaro M. Viljoen1, Dulcie A. Mulholland2, Sandy F. van Vuuren1. 
1Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the 
Witwatersrand, Johannesburg, 2001. 
2 Natural Products Research Group, School of Chemistry, University of KwaZulu-Natal, Durban, 4041 
 
PURPOSE: 
To evaluate the biological activity and phytoconstituents of selected species of the previously 
unresearched genus, Hermannia, that is used in African traditional healing. 
  
METHODS: 
Ten species of Hermannia were chosen due to their widespread use in traditional medicine. 
Plants were collected and crushed into powder. Acetone extracts of all selected species were 
assessed for antibacterial activity, firstly using the broad screen disc diffusion assay on S. 
aureus (ATCC 12600), B. cereus (ATCC 11778) and E. coli ( ATCC 1175) after which, the  
minimum inhibitory concentrations of the most active species were determined. Bioautograms 
were used to indicate compounds that possessed activity. 
Methanol extracts were used to evaluate the antioxidant activity of the ten selected species 
utilizing the DPPH assay and the IC50 for each plant was calculated.  
Characterization of the phytoconstituents of two species, H. salviifolia and H. cuneifolia was 
attempted. A methanol: dichloromethane (1:1) extract was placed on a column and separated 
using a gradient solvent system. 
Five compounds were isolated from the above species of which two, lupeol and β-sitosterol, 
have been characterized. Lupeol and the crude extract of H. cuneifolia, from which lupeol was 
isolated, were assessed for in vitro anti-inflammatory activity using the 5-lipoxygenase assay. 
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Finally, HPLC-UV-MS was used to analyze the chemical diversity of the ten species. 
 
RESULTS: 
Three species, H. cuneifolia, H. althaeifolia and H. saccifera possessed antimicrobial activity 
with H. saccifera indicating remarkable activity with a MIC of 19.5 µg/ml against two 
bacterial species.  
 
Nine species possessed promising antioxidant activity with IC50 of between 10-30 µg/L. 
Five compounds were isolated of which two have been characterized as being lupeol and β-
sitosterol. In addition lupeol inhibited the 5-lipoxygenase enzyme by 78% at 100ppm. 
However, the crude extract of H. cuneifolia totally inhibited the enzyme. 
Finally, HPLC profiles and corresponding UV spectrums indicate extensive similarities 
between the species, which is corroborated by the TLC plates with the exception of H. 
saccifera, which appears to be chemically anomalous. 
 
CONCLUSIONS: 
The results indicate some correlation, albeit in vitro, between the biological activity and 
traditional use of these plants which include treating wounds and burns as well as infections 
Since this is, surprisingly, the first study to be conducted on this genus, isolation of these 
active compounds may produce interesting bioactive compounds that may play an important 
role in the treatment of diseases. 
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